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ABSTRACT

In comparison to other Pseudomonas, P. aeruginosa grows poorly in L-lysine as a sole source of
nutrient while fast growth mutants can be obtained. The proposed catabolic pathway involves
lysine decarboxylation to cadaverine and its subsequent degradation through -glutamylation
pathway to -aminovalerate and glutarate. The lysine decarboxylase A (ldcA) gene, previously
identified as a member of the ArgR regulon of L-arginine metabolism, was found essential for Llysine catabolism. The ldcA gene encodes a decarboxylase which takes L-lysine but not Larginine as substrate. Contrarily, the ldcA expression was inducible by L-arginine but not by Llysine. This peculiar arginine control on lysine utilization was also noted from uptake
experiments. The lack of lysine-responsive control on lysine catabolism and its tight connection
to arginine regulatory network provided an explanation of lysine as poor nutrient for P.
aeruginosa. Catabolism of cadaverine, a product from lysine decarboxylation, was investigated
and compared to that of putrescine, another diamine of similar biochemical properties that is
derived from arginine and ornithine. While the -glutamylation pathway was first reported in E.
coli for putrescine utilization, an expanded version of this pathway was found in P. aeruginosa
with redundant enzymes for polyamine degradation. The PauR protein was identified as a

transcriptional repressor of genes for the catabolism of putrescine and cadaverine, as well as their
corresponding downstream metabolites, -aminobutyrate (GABA) and -aminovalerate (AMV).
PauR shows distinct dimer configuration after glutaraldehyde crosslinkage, and possible
conformational changes could be triggered by the presence of putrescine and cadaverine, but not
GABA. A newly identified ABC transport system, encoded by the agtABCD operon, was found
important for the uptake of GABA and AMV; and expression of which is controlled by the
AgtSR two-component system. The CbrAB two-component system was proposed to regulate the
catabolite repression control protein Crc through a small RNA CrcZ. A consensus CbrB
recognition sequence was proposed based on the conserved palindromic nucleotide sequence in
the upstream activating sequence of the crcZ promoter. Genetic studies indicated utilization of
arginine, lysine and diamines (but not histidine, GABA and AMV) might be under CbrAB
regulation through the CbrAB/CrcZ/Crc system in P. aeruginosa.

INDEX WORDS: Pseudomonas, Lysine, Arginine, Cadaverine, Putrescine, GABA, AMV,
Catabolism, Decarboxylation, -Glutamylation, Uptake, Regulation, Catabolite Repression, TwoComponent System.
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GENERAL INTRODUCTION

Pseudomonas aeruginosa, an opportunistic human pathogen, is the leading source for
pneumonia in immunosuppressed, cystic fibrosis, cancer and burn patients. This Gram-negative
rod-shaped bacterium resides ubiquitously in a wide variety of environments. Exploration of
catabolic pathways is of particular interest in such a nutritionally versatile organism. With the
sequenced genome coupled with an impressive array of genetic and functional genomics tools,
this organism is relatively amenable to investigation.

P. aeruginosa cannot use L-lysine efficiently as sole source of nutrient for growth (19,
85). However, mutants with improved growth on L-lysine can be isolated by repeated
subcultures in L-lysine suggesting existence of catabolic genes on the chromosome (19). In this
study, a peculiar arginine control on lysine utilization was unraveled in P. aeruginosa. The
proposed pathway consists of lysine decarboxylation with formation of cadaverine and its
subsequent degradation through the -glutamylation pathway (Figure 0.1). Catabolic enzymes,
uptake and regulatory systems involved were analyzed in detail using genetic and biochemical
approaches.
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Figure 0.1. Lysine catabolic pathways.
L-lysine decarboxylase pathway leading to cadaverine degradation into 5-aminovalerate
and glutarate is shown in the center as the main route for L-lysine catabolism in P.
aeruginosa. L-lysine transaminase and D-lysine dehydrogenase pathways are shown in
the right. Broken arrows represent L-lysine monooxygenase pathway from P. putida
which is not present in P. aeruginosa. Cadaverine degradation through the glutamylation pathway merges with the monooxygenase pathway of P. putida at
aminovalerate which is further degraded into glutarate.
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0.1 LYSINE CATABOLISM IN PSEUDOMONAS AERUGINOSA

Possible pathways for L-lysine catabolism in bacteria. In microbes, lysine catabolism
can be initiated either through monooxygenase, decarboxylase or transaminase activities (Figure
0.1). While L-lysine is mainly degraded by 2-monooxygenase in P. putida, counterparts for this
pathway are not present in P. aeruginosa (pseudomonas.com). On the other hand, pioneer
biochemical studies using fast-growth mutants suggest lysine decarboxylation as the main
catabolic route in P. aeruginosa (19, 81). Among the several amino acid decarboxylases, those
that attack the basic amino acids, arginine, ornithine and lysine with subsequent polyamine
formation, are the most significant physiologically (23, 29, 65). However, even the enzymology
of this pathway has been established decades ago, lysine decarboxylation and regulatory
mechanism involved were mostly unexplored at the genetic level in P. aeruginosa.

Lysine deaminase activity can be detected in different species of the genus Pseudomonas.
The AruH protein from P. aeruginosa has been studied and characterized as a transaminase able
to remove the 2-amino group from arginine and other amino acids including lysine in vitro (103).
In this study, the role of L-lysine transaminase pathway in P. aeruginosa metabolism will be
investigated using genetics approach.

D-lysine Catabolism. Our laboratory reported a novel racemase system formed by DauA
and DauB to convert D-arginine into L-arginine through two step reactions with 2-keto-arginine
as intermediate compound (52, 53). In these studies, DauA shows high deamination activity with
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D-lysine resulting in ketolysine and ammonia (53). Growth on D-lysine as nitrogen source is
also abolished in dauA mutant strain supporting the in vitro activity of DauA on D-lysine (53).

On the other hand, the product from DauA dehydrogenase, 2-keto-lysine, is supposed to
turn into the more stable cyclic form, 1-piperideine-2-carboxylate (36). Studies from P. putida
suggest D-lysine catabolism with further degradation of this compound into L-pipecolate by the
reductase DpkA (84). However, this pathway is still undefined in P. aeruginosa since no dpkA
orthologue can be found on the chromosome and the corresponding enzymatic activity was not
detectable (19).

0.2 THE ARGININE EFFECT ON LYSINE UTILIZATION

Inducible lysine utilization by arginine. P. aeruginosa has been considered unable to
grow on L-lysine as sole carbon source and grows poorly on this compound as a nitrogen source.
However, initial observations in this study indicate that in fact P. aeruginosa can grow on Llysine as sole carbon and nitrogen source; however, it needs to pass an extensively long lag
phase of approximately 44 hrs before entering the exponential phase with an estimated
generation time of 122 minutes. In addition, this long lag phase can be shortened significantly by
supplementing the media with a small amount of arginine (~100 M). This phenomenon
intrigued me to conduct a series of studies to understand how arginine triggers lysine utilization
in this organism.
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The ArgR regulon contains candidate transport and catabolic genes for lysine. The
ArgR protein was initially identified as the major arginine-responsive transcriptional regulator of
the AraC/XylS family. Using Affymetrix GeneChip® DNA microarray, a group of genes for
basic amino acids uptake and catabolism emerge from the ArgR transcriptome analysis (60).
Interestingly, orthologues of a subset of these genes have been reported as key transport systems
and enzymes for lysine utilization in other bacteria. The transport systems PA5152-PA5155 and
aotJQMP encoding two ABC transporters are the counterparts of PP0283-PP0280 and the
PP4486-PP4482 in P. putida which have been reported to contribute in lysine utilization (82).
These orthologues show high similarities in gene organization as well as in amino acids
sequences (82-84).

Because of its high induction level by arginine, PA1818 was initially proposed as a
catabolic arginine decarboxylase under ArgR control. However, no enzyme activity is detectable
using arginine as substrate in biochemical studies from our laboratory (29). Based on sequence
analysis, PA1818 also possesses potentials to catalyze lysine decarboxylation. Up to date, there
are two lysine decarboxylases identified from E. coli: the lysine decarboxylase C (LdcC) of low
expression level with no response to exogenous lysine; and a well-studied inducible lysine
decarboxylase CadA for acid stress responses (29, 39, 50). LdcC shows higher optimal pH and
lower tolerance to heat than CadA (39, 50). Since PA1818 showed no response to acid stress
(29), this result suggests PA1818 might be the counterpart of the non-inducible decarboxylase
LdcC. And since P. aeruginosa has only one candidate for lysine decarboxylase, other amino
acids decarboxylase systems such as glutamate or arginine decarboxylases might be responsible
for acid stress responses in this organism.
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In this study, ArgR is proposed to regulate lysine utilization which is inducible by
arginine but not by lysine. This hypothesis may give an explanation to the long lag phase for
growth in lysine as sole source of nutrient in P. aeruginosa.

0.3 POLYAMINE CATABOLISM IN MICROORGANISMS

L-lysine catabolism through the decarboxylase pathway leads to formation of cadaverine
(Figure 0.1). On the other hand, ornithine decarboxylation yields putrescine, and L-arginine
decarboxylation, with agmatine as intermediate product, which also leads to putrescine (13, 58).
Many bacteria including Pseudomonas can use cadaverine and putrescine as sole source of
nutrient for growth (12, 13, 93). As a continuation of my study on lysine catabolic pathway,
cadaverine degradation was investigated and compared to putrescine in P. aeruginosa.

Physiological significance of polyamines. Although their functions have not yet been
fully understood, biogenic polyamines (diamines: diaminopropane, putrescine, cadaverine; and
triamines: spermidine, norspermidine and spermine) are natural polycations involved in a wide
range of biological reactions (8, 14, 102). In higher organisms, polyamines are involved in cell
proliferation and differentiation (7). Decades of polyamine biology has been focusing in cell
cycle control since impaired polyamine metabolism can be found in abnormal eukaryotic cells
with high proliferation rates such as cancer cells (6, 62). In microbes, different sets of
polyamines are present in each species which are controlled through uptake, biosynthesis and
catabolism (49, 97). It is believed to bind nucleic acid-containing macromolecules through

7

charge interactions in vivo and are thought to play significant roles in the structural and
functional organization of the chromosome and protect DNA from oxidative damage as free
radical scavengers (26, 33, 38, 97). Exogenous polyamines also exert a significant effect on
antibiotic susceptibility in bacteria (46-48). Other interesting studies link polyamines to
microbial carcinogenesis, escape from phagolysosomes, biofilm formation, bacteriocin
production, toxin activity and protection from oxidative and acid stress, showing the multifaceted
roles of these intriguing molecules in nature (45, 90, 97). While intracellular polyamines play
pivotal roles in ensuring optimal growth, accumulation of these compounds inside the cells may
cause excess binding to DNA forming condensed complexes leading to protein synthesis
inhibition and decrease in cell viability (11, 20, 55). Thus, balanced polyamine
biosynthesis/catabolism and uptake/export appear to be required to adjust the optimal
homeostasis of these compounds in accord with the growth environment.

Cadaverine and putrescine metabolism in bacteria. Cadaverine and putrescine are
diamines with a central methylene chain of similar length: 1,5-diaminopentane, and 1,4diaminobutane, respectively. It was first reported in E. coli that putrescine is degraded into γaminobutyrate (GABA) through the -glutamylation pathway (42, 44). This pathway is initiated
by γ-glutamylputrescine synthetase PuuA, followed by three reactions catalyzed by PuuB, PuuC,
and PuuD.

Recent studies from our laboratory found an expanded version of the -glutamylation
pathway in P. aeruginosa for polyamine catabolism including cadaverine and putrescine.
Different from E. coli, that the puu genes are clustered in a single locus of several transcriptional
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units under negative control of PuuR (44, 70), puu orthologues are scattered on the chromosome
of P. aeruginosa (www.pseudomonas.com). These genes are designated as polyamine utilization
genes pauA, pauB, pauC and pauD (Figure 0.1). Interestingly, there are seven γglutamylpolyamine synthetases (PauA1-7) for the first step of the pathway (105). Many of these
enzymes are able to catalyze the glutamylation of different polyamines. Following the
glutamylation, the free amino group is subjected to deamination either by oxidation or
transamination. Four PauB candidates for oxidative deamination can be found in P. aeruginosa
which are supposed to function only under aerobic conditions. On the other hand, SpuC was
proposed to catalyze transamination between glutamylpolyamine and alanine regardless of the
oxygen level (105). Following deamination, the aldehyde compounds were suggested to be
degraded into carboxylates by the dehydrogenase PauC (KauB) (13), This enzyme was initially
identified as a NAD(P)-dependent dehydrogenase for ketoarginine utilization (104). Since pauC
mutant cannot grow on putrescine, this is the only step without redundant enzymes. And finally,
the glutamyl group is released by PauD in the last step of the pathway. Two -glutamyl
hydrolases were proposed for P. aeruginosa: PauD1 (SpuA) which affects spermidine utilization
but not to putrescine (59); and PauD2 (PA1742) which requires further studies to confirm its
involvement in the pathway.

Regulation on -glutamylation pathway.

Based on studies in E. coli, putrescine -

glutamylation and deglutamylation are negatively regulated by PuuR (Gene ID 945886) in the
first and last steps of the Puu pathway (44). By BLAST search, there is only one candidate for
PuuR orthologue in P. aeruginosa, PA5301, showing 45% identities and 64% similarities to E.
coli PuuR. In the second part of this study, this regulatory protein was shown involved not only
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in the -glutamylation pathway but also in catabolism of their corresponding downstream
metabolites, -aminobutyrate (GABA) and -aminovalerate (AMV).

GABA/AMV catabolism in P. aeruginosa. Like putrescine and cadaverine, it is possible
that the downstream GABA and AMV share similar pathways with common enzymes for the
degradation (12, 42). The gabDT operon encodes for a dehydrogenase GabD and a transaminase
GabT which along with the transaminase GabT2 (PA5313) contribute to GABA degradation into
succinate (13). Besides, it has been reported in P. putida that davDT are the essential genes for
AMV catabolism (82); the DavD and DavT exhibit 92% and 82% sequence similarity to P.
aeruginosa GabD and GabT, respectively. In this study, the roles of gabDT and gabT2 were
investigated for AMV degradation into glutarate.

This study will provide valuable information on the intriguing connection between lysine
catabolism to arginine through arginine-responsive regulatory gene ArgR in P. aeruginosa. This
catabolic pathway became even more complex by redundant enzymes for cadaverine and
putrescine degradation through the -glutamylation pathway. This will be a first complete report
on enzymatic, genetic and regulatory aspects of lysine-cadaverine-aminovalerate degradation in
this organism.

0.4 CARBON CATABOLITE REPRESSION IN PSEUDOMONAS AERUGINOSA

Pseudomonas aeruginosa is noted for its ability to use a wide range of carbon and
nitrogen sources. Different from E. coli and B. subtilis where glucose is the preferential carbon
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source, P. aeruginosa prefers carboxylates of the tricarboxylic acid (TCA) cycle such as
succinate which can exert carbon catabolite repression (CCR) over sugars (including glucose),
amino acids and other nutrients (15, 57, 92). Hallmarks of catabolic regulatory mechanisms like
inducer exclusion and cAMP-dependent transcriptional activation play minor role in CCR
control of this organism. Instead, complex regulatory networks with different regulatory
mechanisms are used to optimize metabolism to achieve efficient growth and cellular carbonnitrogen balance in P. aeruginosa.

While the CbrAB two-component system is essential for growth on several carbon and
nitrogen sources for Pseudomonas (54, 74), the crc (catabolite repression control) gene encoding
a RNA-binding protein has been reported to participate in control of several catabolic operons of
less-preferred nutrients (94). It had been a puzzle to understand how CbrAB and Crc work
together to regulate different catabolic pathways until recent discovery of the small RNA CrcZ
(94). On the other hand, CbrA and CbrB exhibit moderate sequence similarity to the well-studied
NtrB and NtrC two-component system for nitrogen assimilation controls in Gram-negative
bacteria (31, 74). Combined regulation of CbrAB with NtrBC has been reported for arginine and
histidine utilization in pseudomonas (54, 107). The last chapter of this study demonstrates how
CbrAB regulates crcZ to release CCR by the Crc protein. Possible cross talk between CbrAB and
NtrBC two-component systems was also investigated.
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CHAPTER ONE

L-LYSINE CATABOLISM IS CONTROLLED BY L-ARGININE AND ARGR IN
PSEUDOMONAS AERUGINOSA PAO1

This work was partially published by Han-Ting Chou, Mohamed Hegazy and Chung-Dar Lu in
“L-lysine Catabolism is Controlled by Arginine/ArgR in Pseudomonas aeruginosa PAO1”.
J. Bacteriol. 2010 Nov; 192(22):5874-80.
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1.1 INTRODUCTION

Decarboxylation of amino acids, including lysine, arginine, and glutamate, is important for
bacterial survival under low pH (9, 23, 65). Lysine is abundant in rhizosphere where fluorescent
Pseudomonas preferentially reside, and serves as nitrogen and carbon source by these organisms
(85). In microbes, lysine catabolism can be initiated either through monooxygenase,
decarboxylase or transaminase activities. The monooxygenase pathway has been considered as
the major route for L-lysine utilization in Pseudomonas putida, and davBATD encoding enzymes
for the first four steps of the pathway have been characterized (82, 83). In contrast, P. aeruginosa
cannot use exogenous L-lysine efficiently for growth (19, 81). It has been reported that
enzymatic activities for the first two steps of the monooxygenase pathway are not detectable in P.
aeruginosa, and no davBA orthologs can be identified from this organism (81, 82).

Mutants of P. aeruginosa with improved growth on L-lysine and a high level of lysine
decarboxylase activity can be isolated by repeated subcultures in L-lysine (19). This suggests
that in P. aeruginosa, L-lysine utilization might be mediated by lysine decarboxylase pathway
with cadaverine and 5-aminovalerate as intermediates. Alternatively, conversion of L-lysine into
5-aminovalerate may also be accomplished by a coupled reaction catalyzed by AruH and AruI.
The AruH and AruI enzymes were reported as arginine:pyruvate transaminase and 2-ketoarginine
decarboxylase, respectively (104). Interestingly, transamination by AruH using L-lysine as amino
group donor can also be detected in vitro (103). The reaction product -keto--aminohexanoate
can potentially be decarboxylated into 5-aminovalerate by AruI providing an alternative route for
lysine degradation.
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In this study, the lysine decarboxylase pathway was shown to be the main route for lysine
utilization under arginine control. Expression of the ldcAB operon encoding L-lysine
decarboxylase and a putative lysine/cadaverine antiporter was analyzed regarding its response to
L-lysine, L-arginine, and the arginine-responsive regulator ArgR. Enzyme characterization was
performed to verify the function of LdcA as L-lysine decarboxylase. Arginine control on lysine
incorporation was also investigated by genetic studies and uptake experiments. The peculiar role
of ArgR controlling arginine and lysine uptake and catabolism provides the explanation for poor
growth in lysine, and it implies a higher level of complexity in metabolic networks of
pseudomonads.
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Table 1.1. Strains and Plasmids
Genotype or descriptiona

Strain or plasmid

Source

E.coli strains
DH5

F-Φ80dlac ∆M15 ∆(lacZYA-argF)U169 deoR recA1
endA1 hsdR17 (rK- mK-) supE44 λ- thi-1gyrA96 relA

Bethesda
Research
Laboratories

TOP10

F- mcrA (mrr-hsdRMS-mcrBC) 80lacZM15
DlacX74 recA1 araD139 (ara-leu)7697 galU galK
rpsL (StrR) endA1 nupG
thi-1 thr leu tonA lacY supE recA::RP4-2-Tc::Mu
(Kmr)

Invitrogen

PAO1

Wild type

(27)

PAO1-Smr

Spontaneous Smr mutant strain of PAO1

(35)

PAO501

argR::Gmr

(76)

PAO1214

aotJ::Tn5-751 insertion mutant of PAO1

(76)

PAO5715

aruC~aruE::Gmr

This study

PAO5716

ldcA::Tcr

This study

PAO5717

ldcB::Tcr

This study

PAO5602

aruH::Tcr ∆aruF

(104)

PAO5718

aruC~aruE::Gmr, ldcA::Tcr

This study

PAO5720

aruH::Tcr

This study

PAO5721

aruI::Tcr

This study

PAO5802

dauA::Tcr

(27, 53)

SM10

(91)

P. aeruginosa strains
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Plasmids

a

pRTP1

Ampr Sms conjugation vector

(95)

pRTP2

pRTP1 derivative EcoRI site deleted

(52)

pGM1

(88)

pUCP18

Bla gen; gentamicin resistance gene cassette with
omega loop on both ends
Escherichia-Pseudomonas shuttle vector.

pHC5306

pUCP18 derivative carrying ldcA gene

This study

pHC5307

pUCP18 derivative carrying aruH gene

This study

pBAD-His6

(52)

pBAD-ldcA

Modified protein expression vector derived from
pBAD-HisA
6 x His-tagged LdcA protein expression vector

pQF50

bla lacZ transcriptional fusion vector

(18)

pQF52

(76)

pST500

bla lacZ translational fusion vector derived from
pQF50
aotJ::lacZ translational fusion of pQF52

pZY5

PA4980::lacZ translational fusion of pQF52

(104)

pHT1818

ldcA::lacZ transcriptional fusion of pQF50

This study

(89)

This study

(75)

Camr, chloramphenical resistance; Kmr, kanamycin resistance; Smr, streptomycin resistance;
Sms, streptomycin sensitive; Tcr, tetracycline resistance; Gmr, gentamicin resistance; Ampr,
ampicillin resistance.
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1.2 MATERIALS AND METHODS

Bacterial strains, plasmids, media, and growth conditions. Bacterial strains and plasmids
used in this study are listed in Table 1.1. E. coli and P. aeruginosa strains were grown in LuriaBertani (LB) medium supplemented with or without antibiotics at conventional concentrations
(104). Minimal medium P containing the indicated carbon sources at 20 mM and nitrogen
sources at 5 mM was used for the growth of P. aeruginosa (27).

Construction of ldcA::lacZ fusion. The upstream regulatory region of the ldcAB operon
covering 635-bp upstream from of the start codon and the first 24-bp of the structural gene was
PCR amplified from the genomic DNA of P. aeruginosa PAO1 using the following primers: 5‟TCA CTC TGG GCG CAA GCT TAG GCG CCG GTC GGC-3‟ and 5‟-GGG AAA TTT GAG
GTC TTT-3‟. PCR product was cloned into pQF50 and confirmed by DNA sequencing.

Construction of mutant strains. For tetracycline resistant mutants, DNA fragments
covering the genes of interest were PCR amplified from PAO1 genomic DNA using the
following primers: for ldcAB mutants, 5‟-ATG TAT AAA GAC CTC AAA TTT CCC GTC CTC3‟ and 5‟-TCA GTC ATT GGC TTT GAG CGT CGG CAC TCC-3‟; for aruHI mutants, 5‟-GTC
TAA GCT TGA CTG GCC TGG CGC GCG TCG-3‟ and 5‟-CGC AAG CTT CGG GCA GTC
CGG CGT GAC CCT-3‟. PCR products were cloned into a conjugation vector pRTP1 (95) and
the tetracycline resistance cassette was introduced by using EZ-Tn5 <TET-1> insertion system
(Epicentre). For gentamicin deletion mutants, two flanking regions of a targeted gene were
amplified by PCR with following primers: 5‟- GAG GGA TCA CTC GGG TGC ATA CTT CTT

17

CTA CG -3‟, 5‟-GAG GAA TTC AGC GCT TCC AGG TCG TTG TAG -3‟, 5‟-GAG GAA TTC
GAG CGC TAC GTC GAA CAG GAC ATG A -3‟ and 5‟- GAG AAG CTT CAA TCC GAG
CAG GTT GCT CAT GGT C -3‟. The PCR products were cloned into pRTP1. A cassette
carrying gentamicin-resistance gene from pGM1 was inserted into the conjunction of the two
DNA fragments (88). For gene replacement, E. coli SM10 was served as the donors in biparental
mating with PAO1-Smr (21). The desired knockout mutants were selected on LB plates
containing streptomycin and either gentamicin or tetracycline, and the mutation was confirmed
by PCR.

Constitutive expression from pUCP18. Full length ldcA (PA1818) and aruIH
(PA4976~PA4977) genes were successfully PCR amplified and subcloned into pUCP18 to
construct pHC5306 and pHC5307 using the following primers: PA1818F 5‟-TGA AGA TCT
GAG GAG TCA ACA ATG TAT AAA GAC CTC-3‟, PA1818R 5‟-CCC AAG CTT TCA TTC
CTT TAT GCA TTC AAC GGT-3‟, PA4976F 5‟-CAC GGA TCC GCT TGT GGG AAT GGG
AGC AAG AGC-3‟ and PA4976R 5‟-CAC AAG CTT CAT CGT GGT TTC CGA ATC GTG
GTG AC-3‟. These plasmids can reach 10 to 25 copy numbers per cell with constitutive
expression in P. aeruginosa (89).

Measurements of β-galactosidase activity. The cells were grown in the minimal medium P
containing the carbon and nitrogen sources as indicated. Cells in the mid-log phase were
harvested by centrifugation, and then passed through a French press cell at 8500 lb/in2 The cell
debris were removed by centrifugation at 20,000 g for 15 min, at 4 C, and protein
concentrations in the crude extracts were determined by the Bradford method (5). The levels of
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β-galactosidase activity were measured using Miller‟s method (64).

Overexpression and purification of LdcA. Full-length ldcA was amplified from the
genomic DNA of P. aeruginosa using designed primers: 1818F 5‟-TAT AAA GAC CTC AAA
TTT CCC GTC-3‟ and 1818R 5‟-TCA TTC CTT TAT GCA TTC AAC GGT -3‟. The PCR
product was sub-cloned into pBAD-HisD, a modified pBAD expression vector (52, 103).
Recombinant 6xHis-LdcA was expressed in Escherichia coli TOP10 (Invitrogen life
technologies) by arabinose induction. Cell extract was obtained by passing through a French
pressure cell at 8,500 lb/in2 followed by centrifugation at 25,000 g for 30 minutes at 4 C.
Soluble His-LdcA protein was purified from HisTrap HP column (GE Healthcare) at the
concentration of 100 mM imidazole. Eluted fractions detected by UV were analyzed by SDS
PAGE, pooled together and concentrated by Amicon Ultra-15 centrifugal filter unit (Millipore).
Active fractions were determined by lysine decarboxylase assay as described below. Protein
concentration was determined by the method of Bradford (5).

Measurements of lysine decarboxylase activity. Purified His-LdcA was used to test Llysine decarboxylation in vitro. Enzyme-catalyzed decarboxylation was assayed by measuring
the liberated
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CO2 at 37 ºC as previously described with slight modification (101). The assay

was carried out in a standard scintillation vial and the liberated

14

CO2 was trapped by a filter

paper pre-impregnated with 0.1 ml barium hydroxide in the cap. One milliliter of standard
reaction mixture contains 125 M pyridoxal 5‟-phosphate, 100 g/ml acetylated bovine serum
albumin, 0.2 Ci [14C]-L-lysine and 3 mM of cold L-lysine in 100 mM Tris buffer at pH 8.5. The
mixture was incubated at 37 ºC in water bath and the reaction was started by adding 1.5 g of
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purified LdcA. Reaction was stopped by adding seven drops of 1N H2SO4, and continued the
incubation for 30 min more for complete absorption of CO2. Labeled CO2 was measured in a
liquid scintillation counter. Apparent kinetics parameters were determined using non-linear
regression equations of the kinetics module of SigmaPlot 9.0 software.

L-lysine uptake experiments. Radiolabeled L-lysine was used for uptake assays as
previously described with slight modification (59). Cultures were grown in glutamate-MMP in
the absence or presence of 20 mM L-arginine or L-lysine. Cells were harvested during
logarithmic growth (OD600 = 0.5~0.8), washed twice and resuspended at a concentration of ca.
108 cells/ml (OD600 = 0.1) using MMP containing chloramphenicol (250 μg/ml). After incubation
of the cell suspension for 5 min in 37°C water bath,
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C-labeled L-lysine was added to a final

concentration of 20 μM (10 mCi/mmole), and samples (0.5 ml) were withdrawn at various time
intervals. Cells were collected on a cellulose membrane filter (0.22 μm pore size, type GS,
Millipore) and washed with 10 ml of MMP. Membranes were air dried in clean scintillation vials
overnight. Incorporated radioactivity was measured using adequate scintillation liquid and
spectrometer (Beckman).

DNA microarray. GeneChip® P. aeruginosa Genome Array from Affymetrix was used for
transcriptome analysis of physiological responses to different nutrients in P. aeruginosa. All
cells were grown aerobically in minimal medium P with 350 rpm shaking at 37 C supplemented
with 20 mM L-glutamate as background nutrient until optical density at 600nm reaches 0.55 ±
0.05. Cells were harvested by centrifugation for 5 minutes at 4 C. Total RNA samples were
isolated by RNeasy purification kit following instructions of the manufacturer (Qiagen). Reverse
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transcription for cDNA synthesis, fragmentation by DNase I treatment, cDNA probe labeling and
hybridization were performed according to the instructions of GeneChip® manufacturer
(Affymetrix). Data were processed by Microarray Suite 5.0 software normalizing absolute
expression signal values to a target intensity of 500. GeneSpring GX software (Silicon Genetics)
was used for expression pattern analysis and comparison. Genes showing consistent expression
profiles in duplicates were selected for further analysis. All data were deposited in the Gene
Expression Omnibus (GEO) database (GSE9926).

21

1.3 RESULTS

ArgR dependent induction of the ldcA promoter by arginine but not by lysine. The
putative ldcAB operon was initially identified as a member of the ArgR regulon from
transcriptome analysis (60). ArgR is autoinducible from the aot-argR operon and is initially
identified as the major regulator of aerobic arginine catabolism and biosynthesis in response to
arginine (76). The ldcA promoter in response to exogenous L-arginine and L-lysine was tested by
measurements of β-galactosidase activities in PAO1 harboring pHT1818, a PldcA::lacZ fusion. As
shown in Table 1.2, exogenous arginine but not lysine exerted strong induction effect (12 folds)
on the ldcA promoter.

The ldcA gene was shown essential for lysine utilization. The results of ldcA expression
in response to arginine from above experiments led me to propose ldcA encodes an arginineinducible arginine decarboxylase (ADC), the first enzyme of the ADC pathway (69). Arginine
succinyltransferase (AST) and arginine transaminase (ATA) pathways were reported to sustain
for aerobic growth in P. aeruginosa (104). In order to test for ADC pathway as an alternative
route for arginine utilization, I used a double mutant strain PAO5602 devoid of the AST (by aruF
deletion) and ATA (by aruH::Tcr) pathways while the putative ADC pathway remained intact
(Table 1.3). However, growth on L-arginine as sole source of carbon and nitrogen was
completely abolished in PAO5602 and growth on L-arginine can be restored when the mutant
strain was complemented by pHC5307, which expressed aruH from the lac promoter on the
pUCP18 vector (Table 1.4). Contrarily, PAO5602 harboring pHC5306 (ldcA in pUCP18) still
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Table 1.2. Promoter activities of aotJ, and ldcA in response to arginine and lysine

Strain

Genotype

Nutrients

PAO1

Wild type

G

PAO5715

a

aruC~aruE::Gmr

Sp act (mole/mg/min)a for:
PldcA::lacZ
PaotJ::lacZ
0.8 (1)
14 (1)

A+G

9.5 (12)

61 (4)

L+G

1.2 (1.5)

18 (1.2)

G

4.1 (1)

58 (1)

A+G

16.0 (4)

105 (2)

L+G

4.0 (1)

26 (0.5)

Cells were grown in minimal medium P supplemented with 20 mM of : L, lysine, A, arginine or
G, glutamate. Specific activities represent the averages from three measurements with standard
errors below 5%. Fold changes are in parenthesis.
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Table 1.3. Lysine decarboxylase pathway is the main route for lysine catabolism

a

Supplementsa

Strain

Genotype

Affected
Pathway

PAO1

WT

none

+

++

+++

+++

+++

PAO5716

ldcA::Tcr

LDC

−

−

+++

+++

+++

PAO5717

ldcB::Tcr

LDC

+/−

++

+++

+++

+++

PAO5720

aruH::Tcr

ATA

+

++

+++

+++

+++

PAO 501

argR::Gmr

AST/LDC

−

+

+

++

+++

PAO5602

aruH::Tcr/aruF

AST/ATA

++

+++

−

−

+++

PAO5715 aruC~aruE::Gmr

AST

++

+++

+

++

+++

r
PAO5718 aruC~aruE::Gm
r
ldcA::Tc

LDC/AST

M

M

+

++

+++

Lc

Ln

Ac

An

GN

Logarithmically growing cells were plated on MMP solid agar media supplemented with: Lc,
20 mM lysine + 5 mM ammonia; Ln, 5 mM lysine + 20 mM glucose; Ac, 20 mM arginine + 5
mM ammonia; An, 5 mM arginine + 20 mM glucose; GN, 20 mM glucose + 5 mM ammonia;
Growth at 37°C were recorded daily during 3 days of incubation period: +++, growth in one day;
++, growth in 2 days; +, growth in 3 days; +/−, faint growth in 3 days; −: no growth in 3 days; M:
growth under stress with high mutation rate.
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showed no growth on L-arginine. From these results I concluded that ldcA is not involved in
arginine utilization in P. aeruginosa PAO1.

Surprisingly, the ldcA mutant strain, PAO5716, lost the ability to grow on lysine while
arginine utilization remained unaffected (Table 1.3). Introducing pHC5306 to PAO5716
complemented the growth defect on lysine. Even growth of the wild type strain PAO1 on lysine
can be enhanced by the presence of pHC5306. These data support that ldcA may encode a lysine
decarboxylase that is essential for L-lysine catabolism via the decarboxylase pathway (19).

LdcA as lysine-specific PLP-dependent decarboxylase. To further confirm the enzymatic
function of LdcA in lysine degradation, initial characterization of a purified His-tagged LdcA
was performed with radioactive-labeled L-lysine to determine the reaction rate by measuring the
liberated

14

CO2. As shown in Figure 1.1A, LdcA possesses calculated Km and Vmax values of

0.73mM and 2.2 mole/mg/min, respectively. An estimated Hill slope of 2.0 indicated
cooperative substrate activation by L-lysine. The decarboxylase activity of LdcA was also
checked with 14C-labeled L-arginine as substrate, and no activity on L-arginine can be detected.

A

pyridoxal

5‟-phosphate

(PLP)

binding

site

of

LdcA

was

predicted

in

A387THSTHKMLAAF398, which shows 90% and 91 % similarities to the PLP binding sites of E.
coli lysine decarboxylase (CadA ; ETESTHKLLAAF) and arginine decarboxylase (AdiA;
ATHSTHKLLNAF), respectively (68). Indeed, when PLP was removed from the reaction
mixture, enzyme activity was abolished for LdcA (data not shown).
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Figure 1.1. Lysine decarboxylase enzyme characterization.
His-tagged LdcA protein was purified from E. coli. Enzyme-catalyzed lysine
decarboxylation was assayed by measuring the liberated 14CO2 as previously described in
methods. A, Kinetics studies exhibiting cooperative substrate activation pattern with the
corresponding Hill slope plot. Assays with increasing lysine concentrations were
performed at pH 8.5, 37°C. B and C, Optimal conditions for lysine decarboxylation were
tested as described in methods. D, Cold polyamines or amino acids (5 mM) were added
into the standard reaction mixture to test for allosteric effects.
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The optimal pH and temperature for LdcA were also determined. As shown in Figure 1.1C
and 1.1D, LdcA exhibited a maximum activity around 37ºC, pH 8.5 with L-lysine as substrate.
At pH 6, almost no activity was detectable for LdcA in this acidic environment (data not shown).
These results strongly suggest that LdcA may not be involved in acid stress as E. coli CadA and
AdiA do (9, 63, 100) but rather is suitable for lysine catabolism under alkaline conditions.

The potential effects of L-arginine and compounds derived from L-arginine/ornithine/lysine
decarboxylation (agmatine, putrescine, and cadaverine) on LdcA were tested. An inhibition effect
was detected by the last three compounds but not by L-arginine (Figure 1.1B). These results
imply that arginine intervention on lysine utilization is exerted only at the transcriptional level,
and that lysine decarboxylation is subjected to product inhibition by cadaverine and other
polyamines.

Lysine uptake was enhanced by exogenous arginine but not lysine. Arginine effect on
lysine utilization may range from uptake to degradation. In order to investigate this hypothesis,
lysine uptake was examined in a pair of isogenic strains of P. aeruginosa, PAO1 (wild type) and
PAO501 (argR::Gm-R). Cells were grown in minimal medium P with L-glutamate as the
background nutrient with or without addition of exogenous L-arginine or L-lysine. The uptake of
lysine in cell suspensions was examined. As shown in Figure 1.2, uptake of lysine was
significantly induced by the presence of exogenous arginine but not by lysine. Interestingly, this
arginine inducible lysine uptake was also ArgR dependent.
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A.

B.

Figure 1.2. Enhanced lysine uptake by arginine.
Induction of L-lysine uptake by exogenous arginine in A, P. aeruginosa PAO1 and B, its argR
mutant. Cultures grown in glutamate-MMP in the absence (diamond) or in the presence of Larginine (square) or L-lysine (triangle) were harvested during exponential growth and used for Llysine transport assays as described in Materials and Methods.
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Improved growth on lysine by exogenous arginine in PAO1. All my data indicated that
expression of ldcA, the essential gene for lysine catabolism, is controlled by ArgR in response to
L-arginine but not to L-lysine. In the wild type strain PAO1, the estimated generation time was
about 122 minutes when grown on L-lysine; however, it experienced a long lag phase of 44±2 h.
I reasoned this growth curve as lack of ldcA induction by exogenous lysine, and hypothesized
that growth of PAO1 on lysine can be improved by a trace amount of L-arginine to kick off ldcA
expression. Indeed, addition of 0.15 mM L-arginine removed completely the otherwise long lag
phase while the generation time remained unchanged (data not shown).

The basal level of ldcA expression is elevated in the mutant devoid of the major
arginine catabolic pathway. In analysis of the growth phenotype of PAO5602 (an arginine nogrower), I observed significant improvement of this strain on lysine in comparison to PAO1
(Table 1.3). Similar growth behavior on lysine was also detected in PAO5717, an aruC-E
deletion mutant devoid of the major pathway (AST) for arginine catabolism (35). One hypothesis
was that the intracellular level of arginine may be elevated when the major catabolic pathway is
blocked, which in turn activates ArgR to induce the ArgR regulon (60) including the aotJQMOPargR operon for uptake and regulation, ldcAB, and many others. To test this hypothesis, I
compared the activities of aotJ and ldcA promoters from lacZ fusions in PAO1 and PAO5717. As
shown in Table 1.2, the basal level of these two promoters was increased 4-5 fold in PAO5717,
and they were still responsive to the presence of arginine but not lysine in both strains. These
results support the hypothesis of an activated ArgR regulon and hence high lysine uptake and
catabolism in AST mutant strains.
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Potential

lysine

catabolism

by

transamination.

While

the

LdcA-catalyzed

decarboxylation appeared to be the major route for lysine catabolism, L-lysine can potentially be
degraded by other approaches, e.g. transamination. One possible candidate was AruH, which has
been studied and characterized in vitro as a transaminase able to remove the α-amino group from
arginine and lysine (103). Although the ldcA mutant lost completely the capability to grow on Llysine as sole source of carbon and/or nitrogen (Table 1.3), introducing aruH carried on
pHC5306 to this mutant indeed restored growth on lysine as sole source of nitrogen but not
carbon (Table 1.4).

Transcriptome analysis reveals lysine-inducible genes. DNA microarray experiments
were performed to understand genome-wide responses of P. aeruginosa PAO1 to exogenous Llysine and L-arginine at exponential growth phase. The results showed no response to exogenous
lysine of the uptake and catabolic genes for lysine utilization identified in this chapter (Tables
1.5). This reinforces the model of lysine utilization under arginine control.
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Table 1.4. Effects of constitutive expression of ldcA or aruH

Strain
PAO1

PAO5716

Supplementsa

Affected
Pathway

Plasmid

none

pUCP18

LDC

Lc

Ln

Arg

Agm

WT, pUCP18

+

++

+++

+++

pHC5307

WT, pUCP18/aruH

+

+++

+++

+++

pHC5306

WT, pUCP18/ldcA

+++

+++

+++

+++

pUCP18

ldcA::Tcr, pUCP18

−

−

+++

+++

pHC5307

ldcA::Tcr,
pUCP18/aruH
ldcA::Tcr,
pUCP18/ldcA

−

+++

+++

+++

+++

+++

+++

+++

+++

+++

−

+++

+++

+++

+++

+++

+++

+++

−

+++

pHC5306
PAO5602

ATA/AST

pUCP18
pHC5307
pHC5306

a

Genotype

aruH::Tcr/aruF,
pUCP18
aruH::Tcr/aruF,
pUCP18/aruH
aruH::Tcr/aruF,
pUCP18/ldcA

Logarithmically growing cells were subjected to growth phenotype test in MMP media
supplemented with: Lc, 20 mM lysine + 5 mM ammonia; Ln, 5mM lysine + 20 mM glucose; Arg,
20 mM arginine; Agm, 20 mM agmatine; and GN, 20mM glucose + 5 mM ammonia. Aerobic
growth at 37°C was monitored during 3 days: +++, prominent growth in 1 day; ++, growth in 2
days; +, growth in 3 days; −, no growth in 3 days.
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Table 1.5. L-arginine inducible genes for lysine utilization selected from DNA microarray analysis
Signal Valueb
PA IDa

Glu

Glu

Glu

Glu

Glu

Glu

Glu

Arg

Put

GABA

Lys

Cad

AMV

aotJ

1911

7331 (4)

1567 (1)

1228 (1)

1067 (1)

1369 (1)

1262 (1)

arginine/ornithine binding protein

PA0889

aotQ

432

2157 (5)

318 (1)

399 (1)

453 (1)

470 (1)

303 (1)

arginine/ornithine transport protein

PA0890

aotM

700

2962 (4)

516 (1)

781 (1)

806 (1)

807 (1)

822 (1)

arginine/ornithine transport protein

PA0892

aotP

1461

4401 (3)

1051 (1)

1500 (1)

1959 (1)

2167 (1)

2039 (1)

arginine/ornithine transport protein

PA0893

argR

671

2090 (3)

526 (1)

606 (1)

1050 (2)

1114 (2)

1135 (2)

transcriptional regulator

PA5152

1918

4617 (2)

1377 (1)

935 (0)

1786 (1)

1210 (1)

1185 (1)

ATP-binding component of ABC transporter

PA5153

4771

14117 (3)

2954 (1)

1298 (0)

4147 (1)

2141 (0)

2160 (0)

periplasmic binding protein

PA5154

912

2371 (3)

383 (0)

271 (0)

1410 (2)

750 (1)

694 (1)

permease of ABC transporter

PA5155

607

2105 (3)

327 (1)

194 (0)

372 (1)

319 (1)

270 (0)

permease of ABC transporter

PA0888

Gene

Annotations

PA1818

ldcA

581

3070 (5)

531 (1)

379 (1)

997 (2)

712 (1)

603 (1)

lysine decarboxylase

PA1819

ldcB

190

796 (4)

152 (1)

134 (1)

445 (2)

579 (3)

500 (3)

probable lysine/cadaverine antiporter

83

225 (3)

70 (1)

71 (1)

345 (4)

55 (1)

93 (1)

NAD(P)H quinone oxidoreductase

98

192 (2)

80 (1)

83 (1)

630 (6)

133 (1)

53 (1)

Arginine:Pyruvate Transaminas

68

PA4975
PA4976

aruH

PA4977

aruI

149 (2)

80 (1)

130 (2)

424 (6)

119 (2)

121 (2)

2-ketoarginine decarboxylase

PA4978

108

177 (2)

81 (1)

80 (1)

940 (9)

292 (3)

171 (2)

hypothetical acetyl-CoA C-acetyltransferase

PA4979

83

17 (0)

44 (1)

27 (0)

887 (11)

168 (2)

69 (1)

probable acyl-CoA dehydrogenase

PA4980

122

687 (6)

232 (2)

149 (1)

2241 (18)

66 (1)

95 (1)

putative enoyl-CoA hydratase/isomerase

54
54 (1)
43 (1)
189 (4)
39 (1)
probable amino acid permease
PA4981
573 (11)
5855 (108)
The PA ID numbers were taken from the PAO1 genome annotation project (www.pseudomonas.com).
b
GeneChip raw data are mean values from two independent sets of cultures. Cells were grown in minimal medium P supplemented with 20 mM of the following
supplements as indicated: Glu, glutamate; Arg, L-arginine; Put, putrescine; GABA, -aminobutyrate; Lys, L-lysine; Cad, cadaverine; AMV, -aminovalerate.
Fold changes are in parenthesis.
a
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Table 1.6. L-lysine inducible genes selected from DNA microarray analysis
Signal Valueb
PA IDa

Gene
Glu

Glu

Glu

Glu

Glu

Glu

Arg

Put

GABA

Lys

Cad

AMV

Annotations

PA0446

169

45(0)

127(1)

66(0)

1263(7)

1699(10)

2294(14)

Predicted acyl-CoA transferase

PA0447

167

134(1)

141(1)

189(1)

9747(58)

7201(43)

9184(55)

glutaryl-CoA dehydrogenase

64

144(2)

107(2)

60(1)

600(9)

525(8)

617(10)

conserved hypothetical protein

ppyR

49

140(3)

96(2)

54(1)

923(19)

614(13)

939(19)

psl and pyoverdine operon regulator

PA2664

fhp

14

6(0)

15(1)

6(0)

1602(114)

618(44)

1490(106)

PA1027

amaA

100

20(0)

124(1)

76(1)

1230(12)

197(2)

238(2)

-aminoadipate -semialdehyde
dehydrogenase

PA1028

amaB

87

243(3)

109(1)

98(1)

483(6)

231(3)

144(2)

L-Pipecolate oxidase

PA4181

171

323(2)

174(1)

164(1)

5721(33)

432(3)

385(2)

hypothetical protein of unknown function

PA4182

189

306(2)

252(1)

179(1)

8959(47)

423(2)

457(2)

hypothetical transcriptional factor

PA4364

56

58(1)

38(1)

58(1)

2448(44)

125(2)

30(1)

hypothetical protein of unknown function

PA4365

54

70(1)

52(1)

26(0)

2304(43)

181(3)

111(2)

probable lysine exporter

gcdH

PA2662
PA2663

a

Glu

flavohemoprotein

The PA ID numbers were taken from the PAO1 genome annotation project (www.pseudomonas.com).
GeneChip raw data are mean values from two independent sets of cultures. Cells were grown in minimal medium P supplemented with 20 mM of the following
supplements as indicated: Glu, glutamate; Arg, L-arginine; Put, putrescine; GABA, -aminobutyrate; Lys, L-lysine; Cad, cadaverine; AMV, -aminovalerate.
Fold changes are in parenthesis.
b
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In contrast, a group of 11 genes in five putative operons was subjected to specific induction
by L-lysine but not L-arginine (Table 1.6). Among them, the PA0446-PA0447 and PA2662PA2664 operons were inducible either by L-lysine, cadaverine or AMV. PA0446 encodes a
putative acyl-CoA transferase, and PA0447 (gcdH) a glutaryl-CoA dehydrogenase. This locus
might be involved in lipid and amino acid catabolism (96). On the other hand, PA2662-PA2664
operon seems related to nitric oxide (NO) detoxification. PA2664 (fhp) encodes a
flavohemoglobin with NO reductase activity under anaerobic conditions and NO dioxygenase
activity under aerobic conditions (2, 80). PA2663 (ppyR) encodes a membrane sensor protein.
Upon ppyR inactivation, defective biofilm formation and quorum sensing were reported in P.
aeruginosa (3). And PA2662 encodes a membrane protein predicted for response to NO.

Among the lysine inducible genes, six genes in three operons were specifically inducible
by L-lysine but not by its downstream metabolites cadaverine or AMV (Table 1.6). The first
operon, PA1027-PA1028, is the counterpart of amaA-amaB, encoding important enzymes of the
D-lysine catabolic pathway in P. putida (82, 84). 2-ketolysine derived from lysine deamination is
spontaneously converted into 1-piperidine-2-carboxylate, a cyclic form of higher stability (36).
In P. putida, 1-piperidine-2-carboxylate derived from D-lysine deamination leads to Lpipecolate biosynthesis by DpkA which in turn is channeled to aminoadipate by AmaB and
AmaA (82, 84). AmaB, a FAD-dependent oxidoreductase, converts L-pipecolate into 1piperidine-6-carboxylate, and AmaA, an aldehyde dehydrogenase, synthesizes 2-aminoadipate
from 1-piperidine-6-carboxylate. The existence of the ama locus in P. aeruginosa is intriguing
since the dpkA gene for L-pipecolate synthesis is absent on the chromosome. Possible
explanation might be a cross reaction of AmaA with 1-piperidine-2-carboxylate. However, no
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growth on lysine in lysine decarboxylase ldcA deficient strain suggested limited role of AmaA
and AmaB in lysine utilization. The second operon, PA4181-PA4182, encodes hypothetical
proteins of unknown function. PA4182 might be a transcriptional regulator with a FMN-binding
domain. More studies are required to investigate the functions of these genes. The third and last
operon of this group, PA4364-PA4365, encodes a hypothetical protein of unknown function and
a putative lysine exporter with six transmembrane helices. This LysE type transporter is
predicted to excrete excess lysine from the cell as in C. glutamicum (99). Induction of this
exporter may suggest that L-lysine were taken up but needed to be pumped out due to
intracellular accumulation.
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1.4 DISCUSSION

The bottleneck of lysine catabolism. The most intriguing finding in this study was that
both lysine uptake and degradation are inducible by L-arginine and show no response to L-lysine.
The arginine dependent ldcA expression was revealed from its promoter activities; and electromobility shift assays also revealed interactions of the arginine-responsive regulator ArgR to its
putative binding site in the promoter region. The lack of lysine-responsive induction on ldcA is
likely the major limiting factor of growth on L-lysine. Growth of P. aeruginosa on L-lysine
exhibited a long lag phase of 44±2 hours. In comparison, growth on cadaverine, the
decarboxylation product of L-lysine by LdcA, has normal lag phase. Indeed putting ldcA under
control of the constitutive lac promoter in a plasmid improved growth significantly.

Conditions that increase the level of intracellular arginine and ArgR could also induce ldcA
expression, and hence promote a better growth on L-lysine. While ldcA was induced under these
conditions, at least two ABC transporter systems for L-arginine were also increased (aotJQMP
and PA5152-PA5155). Interestingly, counterparts of these two systems in P. putida KT2440 have
been reported as candidate L-lysine transport systems in recent studies (83). PP0283-PP0280
and the PP4486-PP4482 show high similarities in gene organization as well as in amino acids
sequences (82% and 76% respectively) with P. aeruginosa, PA5152-5155 and aotJQMP-argR
loci. Together with LdcB, a candidate lysine/cadaverine antiporter, all three candidate transport
systems in P. aeruginosa are regulated by ArgR in response to L-arginine but not to L-lysine.
This may explain the lack of lysine-inducible uptake as another limiting factor for growth on Llysine in P. aeruginosa PAO1.

36

The lysine decarboxylase LdcA is conserved among pseudomonads. In the
Pseudomonas Genome Database (www.pseudomonas.com), orthologs of LdcA can be found in
strains of P. entomophila, P. fluorescens, P. mendocina, P. putida, and P. stutzeri, but not in P.
syringae. For P. putida KT2440, the corresponding gene (PP4140) contains an authentic
mutation that causes a frame shift of the translated product. While gene organization of ldcA and
its upstream dnaQ encoding the epsilon subunit of DNA polymerase III is conserved among
these strains, the downstream ldcB can only be found in strains of P. aeruginosa. In conclusion, it
is reasonable to predict that most species of pseudomonads possess the L-lysine decarboxylase.

Other pathways of lysine catabolism. The aruH gene encodes for an L-arginine and Llysine:pyruvate transaminase (104). Contribution of this enzyme in lysine utilization as the sole
nitrogen source can only be detected when constitutively expressed from a plasmid. However,
AruH may not have any physiological implication on lysine catabolism in PAO1 as the ldcA
mutant showed no growth on L-lysine as the sole source of carbon or nitrogen. Perhaps it was
because of low L-lysine uptake and low affinity of AruH on L-lysine.

The aruH and aruI genes encode the first two enzymes of the arginine transaminase
pathway in P. aeruginosa (104). While aruHI are conserved in P. putida, an extra gene encoding
an amino acid racemase is located between aruH and aruI of this organism. The amino acid
sequence of this racemase contains a predicted signal peptide at the N-terminus, suggesting its
secretion to the periplasm. This implies the role of this additional gene as the racemase to convert
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L-lysine into D-lysine before channeled into the D-lysine catabolic pathway in P. putida (10, 34,
82).

P. aeruginosa can only utilize D-lysine as nitrogen source but not carbon source by the
FAD-dependent dehydrogenase DauA (52). Transamination of L-lysine by AruH or D-lysine by
DauA leads to -keto--aminohexanoate which is spontaneously converted into its cyclic form
Δ1-piperideine-2-carboxylate at physiological pH (40). Recent studies in P. putida suggests
further degradation of this molecule into L-pipecolate by the reductase DpkA (PP3591) (84).
However, viability of this pathway is still undefined in P. aeruginosa since dpkA orthologue is
not present on the chromosome, corresponding biochemical reaction cannot be detected, and no
growth is detectable using D-lysine as carbon source (19).

Lysine decarboxylation is the main route of L-lysine catabolism in P. aeruginosa.
With the purified enzyme, I demonstrated that LdcA is an L-lysine decarboxylase with no
activity toward L-arginine. Genetic studies also indicated that ldcA is essential for L-lysine
utilization in P. aeruginosa. Therefore, I concluded that the lysine decarboxylase LdcA is the
enzyme responsible of the pivotal step of L-lysine catabolism in this organism.

Transcriptome analysis of arginine and putrescine unraveled lysine and cadaverine
catabolic pathways. It had been very confusing the initial studies of the lysine decarboxylase
pathway gene ldcA since it is highly induced by arginine in the DNA microarray data. And none
of the genes for lysine utilization identified in this study were inducible by lysine. Without the
strong arginine background of our laboratory, it would not be possible to discover the arginine
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control on lysine utilization through ArgR. Similarly, I also encountered difficulties analyzing
genome-wide responses to exogenous cadaverine. No obvious hints of catabolic genes for
cadaverine were able to be picked up from this set of DNA microarrays. Fortunately, I performed
transcriptome analysis using putrescine, a similar compound derived from ornithine and/or
arginine, where candidate genes for polyamine -glutamylation were noticed (13). This
motivated me to propose putrescine and cadaverine degradation through -glutamylation
pathway in P. aeruginosa which will be described in Chapter Two of this thesis.
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CHAPTER TWO

CADAVERINE AND PUTRESCINE CATABOLISM THROUGH -GLUTAMYLATION
IN PSEUDOMONAS AERUGINOSA PAO1
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2.1

INTRODUCTION

Cadaverine and putrescine are diamines involved in a wide spectrum of physiological
functions from prokaryotic to eukaryotic cells (45, 90), and intracellular concentrations of these
compounds are finely tuned through biosynthesis, degradation and transport (14). In microbes,
putrescine and cadaverine are synthesized directly from decarboxylation of ornithine (speC) and
lysine (ldcA) respectively (12, 72). Alternatively, endogenous putrescine can also be generated
through arginine and agmatine degradation (13, 73). On the other hand, exogenous putrescine
and cadaverine can be taken as carbon and nitrogen sources by many bacteria including P.
aeruginosa (12, 13, 93). It was first reported in E. coli that putrescine is degraded through the glutamylation pathway (43, 44). This pathway consists of four consecutive reactions with
consumption of ATP in the first step for -Glu-putrescine biosynthesis (Figure 2.1).

In order to understand how P. aeruginosa responds to exogenous polyamines, DNA
microarray experiments had been conducted to get snapshots of gene expression at the
exponential phase of growth (13). A group of redundant genes were identified for glutamylation and were shown essential for polyamine utilization in P. aeruginosa (13, 105).
Different from E. coli, the -glutamylation pathway is more complex by the existence of multiple
homologous enzymes with redundant specificity toward different polyamines for a larger
metabolic capacity in P. aeruginosa (105).
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Figure 2.1. Proposed cadaverine catabolic pathway in P. aeruginosa
Proposed cadaverine catabolism by the -glutamylation pathway was shown above. The Pau
proteins for polyamine utilization were marked. For putrescine glutamylation, PauA1, PauA2
and PauA5 catalyze the first step of the pathway. Also shown were the enzymes GabT, GabT2,
and GabD, for AMV and GABA degradation.
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Alternatively, putrescine was proposed to be degraded without -glutamylation through a
traditional transaminase-dehydrogenase pathway (13). PA0299 (SpuC) and PA5312 (PauC/KauB)
were proposed as putrescine:alanine transaminase and aldehyde dehydrogenase for direct
degradation of putrescine into -aminobutyrate (GABA) due to the growth deficiency on
putrescine of the corresponding mutant strains (13, 59). However, deletion mutants devoid of the
glutamylation pathway cannot grow on polyamines (105). Therefore the direct transaminasedehydrogenase pathway has limited contribution in polyamine utilization, and PA0299 and
PA5312 were proposed to play their roles after polyamine glutamylation.

Putrescine and cadaverine were proposed to be degraded into -aminobutyrate (GABA) and
-aminovalerate (AMV), respectively. To serve as carbon sources, subsequent reactions are
required to degrade GABA into succinate and AMV into glutarate. Based on similarities in
chemistry, pathways with common enzymes for the utilization of GABA and AMV were
proposed (12, 42).

This study was undertaken to investigate the importance of the -glutamylation pathway for
putrescine and cadaverine utilization in P. aeruginosa. Essential Glu-putrescine and Glucadaverine synthetases were identified by genetics approach. Different from putrescine, carbon
catabolite repression was detected for cadaverine utilization. A regulatory protein of the cupin
family, PauR, was identified revealing regulation on putrescine/cadaverine glutamylation and
GABA/AMV degradation through conformational changes. The gabD, gabT and gabT2 genes
for GABA degradation were investigated for AMV degradation into glutarate. In addition to
common catabolic pathways, a newly identified ABC transport system agtABCD under
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regulation of a two-component system agtSR were proven to contribute in both GABA and AMV
utilization. The genetics and regulatory aspects of the -glutamylation pathway for putrescine
and cadaverine utilization in this organism were investigated in this study.
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Table 2.1. Strains and plasmids

Genotype or descriptiona

Source

DH5

F-Φ80dlac ∆M15 ∆(lacZYA-argF)U169 deoR recA1
endA1 hsdR17 (rK- mK-) supE44 λ- thi-1gyrA96 relA

Bethesda
Research
Laboratories

TOP10

F- mcrA (mrr-hsdRMS-mcrBC) 80lacZM15
DlacX74 recA1 araD139 (ara-leu)7697 galU galK
rpsL (Smr) endA1 nupG

Invitrogen

SM10

thi-1 thr leu tonA lacY supE recA::RP4-2-Tc::Mu
(Kmr)

(91)

PAO1

Wild type

(27)

PAO1-Smr

Spontaneous Smr mutant strain of PAO1

(35)

PAO5725

pauA1-A6 (PA0296; PA0298; PA1566;
PA2040::Gmr; PA3356; PA5522)

This study

PAO5722

pauR::Gmr

This study

PAO5701

gabD::Tcr

(13)

PAO5703

gabT::Tcr

(13)

PAO5708

gabT2::Gmr

(13)

PAO5704

gabT/T2 (gabT::Tcr; gabT2::Gmr)

(13)

H103

Wild type

(51)

PAO5723

agtS::lux, ID:PAO1_lux_23_C9

(51)

PAO5724

agtA::lux, ID: PAO1_lux_25_F4

(51)

Strain or plasmid
E. coli strains

P. aeruginosa strains
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Plasmids

a

pRTP1

Ampr Sms conjugation vector

(95)

pGM1

Ampr Gmr; gentamicin resistance gene cassette with
omega loop on both ends

(88)

pQF50

bla; lacZ transcriptional fusion vector

(18)

pQF52

bla; lacZ translational fusion vector derived from
pQF50

(76)

pGU101

spuA::lacZ (for pauA2) translational fusion of pQF52

(59)

pGU102

pauA1(spuI)::lacZ translational fusion of pQF52

(59)

pHT2040

pauA4::lacZ transcriptional fusion of pQF50

This study

pHT3356

pauA5::lacZ transcriptional fusion of pQF50

This study

pHT0603

agtA::lacZ transcriptional fusion of pQF50

This study

pMH105

gabD::lacZ translational fusion of pQF52

(29)

pHT0265-1

palindrome-gabD::lacZ transcriptional fusion of
pQF50

This study

pHT0265-2

No palindrome-gabD::lacZ transcriptional fusion of
pQF50

This study

pHT5313

gabT2::lacZ transcriptional fusion of pQF50

(13)

pBAD-His6

Modified protein expression vector derived from
pBAD-HisA

(52)

pBAD-PauR

6 x His-tagged PauR protein expression vector

This study

pBAD-GabD

6 x His-tagged GabD protein expression vector

This study

pBAD-AgtR

6 x His-tagged AgtR protein expression vector

This study

Smr, streptomycin resistance; Kmr, kanamycin resistance; Gmr, gentamicin resistance; Tcr,
tetracycline resistance; Ampr, ampicillin resistance; Sms, streptomycin sensitive.
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2.2

MATERIALS AND METHODS

Bacterial strains, plasmids, media, and growth conditions. Mutant strains of the agt locus
are from the lux transposon mutant library courtesy of Dr Hancock at University of British
Columbia, Vancouver, B.C., Canada (pseudomutant.pseudomonas.com). Luria-Bertani (LB)
medium was used with the following supplements as required: ampicillin at 100 µg ml-1,
tetracycline at 12.5 µg ml-1, gentamicin at 10 µg ml-1, 5-bromo-4-chloro-3-indolyl-β-Dgalactopyranoside (X-Gal) at 0.03 % (wt/vol) for E. coli; and carbenicillin at 100 µg ml-1,
streptomycin at 500 µg ml-1, tetracycline at 100 µg ml-1 and gentamicin at 100 µg ml-1 for P.
aeruginosa. Minimal medium P (27) containing the indicated carbon sources at 20 mM and
nitrogen sources at 5 mM was used for the growth of P. aeruginosa.

DNA Microarray. DNA microarray experiment was conducted as described in Chapter One.
Data was deposited in the Gene Expression Omnibus (GEO) database (GSE9926).

Construction of a pauR knockout mutant. For deletion mutants, two flanking regions of
the targeted gene were PCR amplified and cloned into pRTP1 using primers: pauR1F 5‟-CGG
GAT CCC GAT CAG AAA TTT GCG GGC GTG G-3‟; pauR1R 5‟- CGG AAT TCC GGC
GCG GTG TCC ATG CGC CTG-3‟; pauR2F 5‟- CGG AAT TCC GGT CGA TCA GTT CGT
CTG CCT -3‟; pauR2R 5‟- CCA AGC TTG GGG TGC TCG TCT GCA AAC CAT -3‟. The
PCR products were cloned into pRTP1. A cassette carrying gentamicin-resistance gene from
pGM1 was inserted into the conjunction of the two DNA fragments (88). For gene replacement,
E. coli SM10 was served as the donors in biparental mating with PAO1-Smr (21). The desired
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knockout mutants were selected on LB plates containing streptomycin and either gentamicin or
tetracycline, and the mutation was confirmed by PCR.

Construction of lacZ fusions. Plasmids pGU101, pGU102 and pHT5313 were used to measure
pauA2, pauA1 and gabT2 promoters activities, respectively (13, 59). Regulatory regions of
gabDT, pauA5 (PA3356), pauA4 (PA2040) and agtA (PA0603) were amplified by PCR from the
genomic DNA of P. aeruginosa PAO1 using the following primers: Pgab_F, 5‟-GGA TTC GTT
TGA GAT TTC AAA CGC CCC-3‟; Pgab_palindrome_R, 5‟-GGG GCG TTT GAA ATC TCA
AAC GAA TCC-3‟; Pgab_no palindrome_R, 5‟-TCT CAA ACG AAT CCT AGG GCC-3‟; P
pauA5_F, 5‟-GGT GG A TCC GAG AAT CAA CGG CAG TAC TC-3‟; PpauA5_R, 5‟-GGT
AAG CTT GAT GCA TTG CAG CAG CAC GCCA-3‟; PpauA4_F, 5‟-GGT GGA TCC TTG
AAC GAT CTT GCT CTT CGT ATC-3‟; PpauA4_R, 5‟-GGT AAG CTT GAA GGA ACA GGC
TCG GCT CAG-3‟; PagtA_F, 5‟-GGT GGA T CC GCA AGC TCG ACG AGC TGA AGC CCT
ATA TC-3‟; PagtA_R, 5‟- GGT AAG CTT GAG TCT CGG CCA TAA CCG CAC CTT TGT
TC-3‟. PCR products were cloned into pQF50 and confirmed by DNA sequencing.

Measurements of LacZ enzyme activity. The cells were grown in the minimal medium P
containing carbon and nitrogen sources as indicated. Cells in the mid-log phase when the optical
density at 600 nm reached 0.7 were harvested by centrifugation, and then passed through a
French press cell at 8500 lb/in2 The cell debris were removed by centrifugation at 20,000 g for
10 min, at 4C, and protein concentrations in the crude extracts were determined by the Bradford
method (5), using bovine serum albumin as standard. The levels of β-galactosidase activity were
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measured at 37˚C using o-nitrophenyl-β-galactopyranoside as the reaction substrate, and the
formation of o-nitrophenol was determined by spectrophotometry at 420 nm (64).

Overexpression and purification of the histidine-tagged PauR and AgtR proteins. Fulllength pauR and agtR were amplified from the genomic DNA of P. aeruginosa using the
following primers: agtR F 5‟- GTG ATC CGA GTC CTG GTC GCT GAA G -3‟, agtR R 5‟GAG GAA TTC TGT CAG AGC AGG CGG TGC TCC ATC-3‟, pauR F 5‟- GAC GTC GGT
GCT CGT CTG CAA ACC -3‟, pauR R 5‟- GAG GAA TTC TTG TGC TTC AGG TCA GAA
ATT TGC-3‟. The PCR products were digested with EcoRI restriction endonuclease and
assembled onto the SmaI and EcoRI sites of pBAD-His6, a modified pBAD expression vector
(52, 103). Recombinant proteins were expressed by arabinose induction in Escherichia coli
TOP10 (Invitrogen life technologies). Cell extract was obtained by passing through a French
pressure cell at 8,500 lb/in2. Soluble fraction was subjected to protein purification using HisTrap
HP column (GE Healthcare) following manufacturer‟s instructions. Protein purity was analyzed
by SDS PAGE and concentration was determined by the method of Bradford (5).

Glutaraldehyde crosslinking. Purified His-PauR was subjected to glutaraldehyde treatment
in 20mM HEPES buffers at pH 7.5. Reaction mixtures with 25µg of purified His-PauR in a total
volume of 100 µl were treated with 5 µl of 2.3% freshly prepared solution of glutaraldehyde for
2 minutes at 25oC followed by 3 minutes at 37oC. The reaction is terminated by addition of 10 µl
of 1 M Tris-HCl (pH 8.0). Diamines, GABA or AMV are incorporated into the reaction mixture
at 1mM concentration either prior glutaraldehyde treatment or after quenching with Tris buffer.
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Cross-linked proteins were analyzed by SDS-polyacrylamide gels electrophoresis and visualized
by ProtoBlue Safe staining (National Diagnostics).

Electrophoretic mobility shift assays. DNA fragments covering regulatory regions were
PCR amplified from the genome using the same primers as for the construction of the cognate
promoter-lacZ fusions. For pauA1/spuA divergent promoters, the following primers were used:
Pspu F 5‟-GTA CCG ACA TGA TGC AAC AC -3‟ and Pspu R 5‟- CAG GCG AGA CAT GAG
ACA C -3‟. For radioactively labeled DNA probes, [γ-32P] dATP were incorporated by
polynucleotide kinase. DNA probes (0.2 ng) were allowed to interact with different
concentrations of purified proteins in a 20 μl reaction mixture containing 50 mM Tris-HCl (pH
8), 50 mM KCl, 1mM EDTA, 5% (v/v) glycerol, and 150 μg/ml acetylated bovine serum
albumin. A smaller DNA fragment amplified from the lipA promoter region was used as negative
control for non-specific binding. The reaction mixtures were incubated for 30 min at room
temperature before applying to a 4% native polyacrylamide gel in 0.5X TBE (pH7.5) buffer.
After being dried, the gel was auto-radiographed by exposure to a phosphorimager plate, scanned
using FLA-7000 version 1.1, and analyzed by Multi Gauge version 3.0 (FUJIFILM). For nonradioactive DNA probes, 1 ng of DNA was used in the reaction mixture and visualized from the
polyacrylamide gel by SYBR green I staining (Invitrogen) followed by Omega UltraLum
imaging system with 473 nm excitation and 520 nm emission wave lengths.
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2.3 RESULTS AND DISCUSSION

Putrescine and cadaverine are the inducer molecules of the -glutamylation pathway.
For the first step of the -glutamylation pathway, seven glutamyl-polyamine synthetases
(PauA1~PauA7) were identified in P. aeruginosa based on sequence homology to E. coli
glutamyl-putrescine synthetase PuuA. Parallelly, DNA microarray experiment showed
PauA1~PauA6 (not PauA7) were inducible by either putrescine or spermidine (Table 2.2). To
confirm involvement of these enzymes in polyamine utilization, a series of deletion knockouts
with different combinations of pauA(s) was performed. Based on these genetics studies, the Glu-polyamine synthetases PauA1, PauA2 and PauA4 were proven essential for growth on
putrescine, and PauA1, PauA4 and PauA5 for cadaverine (Figure 2.1, Table 2.3).

To determine the inducer molecule of the -glutamylation pathway, the pauA promoter
activities in response to exogenous putrescine and cadaverine were measured in the wild type
PAO1 harboring pGU101 (PpauA2::lacZ), pGU102 (PpauA1::lacZ), pHT2040 (PpauA4::lacZ) or
pHT3356 (PpauA5::lacZ). As shown in Figure 2.2, tested pauA(s) promoters were inducible by
either putrescine (>5 folds) or cadaverine (>2.5 folds) in glucose/ammonia minimal medium.
Then I compared the expression profile in the PAO5725 mutant strain where all six -Glupolyamine synthetase genes (pauA1-pauA6) were deleted. As shown in the same graphs, while
the basal expression levels of these four pauA promoters were similar in PAO1 and PAO5725
induction by putrescine and cadaverine were further enhanced (except pauA5 promoter) in
PAO5725 due to internal accumulation of polyamines in this mutant. These data indicate that
putrescine and cadaverine are the inducer molecules of the -glutamylation pathway.
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Table 2.2. Genes for polyamine -glutamylation pathway
Signal Valueb
PA IDa

Gene
Name

Glu

Glu

Glu

Glu

Glu

Glu

Put

GABA

Cad

AMV

Spd

Descriptions

PA0296

pauA1/spuI

1113

7613 (7)

4045 (4)

1055 (1)

1211 (1)

5044 (5)

glutamylpolyamine synthetase, pauA4 (PA2040) homolog

PA0297

pauD1/spuA

275

1663 (6)

1260 (5)

341 (1)

214 (1)

1926 (7)

putative γ-glutamyl hydrolase

PA0298

pauA2/spuB

582

2625 (5)

1892 (3)

459 (1)

502 (1)

4244 (7)

glutamylpolyamine synthetase

PA0299

spuC

1203

6179 (5)

4112 (3)

2331 (2)

2893 (2)

7115 (6)

aminotransferase

PA0534

pauB1

26

398 (15)

555 (21)

883 (34)

250 (10)

42 (2)

FAD-dependent oxidoreductase

PA1565

pauB2

58

42 (1)

62 (1)

140 (2)

175 (3)

2111 (36)

FAD-dependent oxidoreductase

PA1566

pauA3

23

13 (1)

46 (2)

22 (1)

19 (1)

2057 (89)

glutamylpolyamine synthetase

PA1742

pauD2

366

1605 (4)

2292 (6)

606 (2)

685 (2)

762 (2)

putative γ-glutamyl hydrolase

PA2776

pauB3

194

2555 (13)

5078 (26)

186 (1)

327 (2)

460 (2)

FAD-dependent oxidoreductase

PA3356

pauA5

591

3232 (5)

1687 (3)

1635 (3)

1960 (3)

3240 (5)

glutamylpolyamine synthetase

PA5309

pauB4

398

1007 (3)

1316 (3)

690 (2)

703 (2)

477 (1)

FAD-dependent oxidoreductase

PA5508

pauA7

128

119 (1)

155 (1)

156 (1)

272 (2)

79 (1)

glutamylpolyamine synthetase

PA5522

pauA6

116

591 (5)

411 (4)

265 (2)

282 (2)

566 (5)

glutamylpolyamine synthetase

PA5312

pauC/kauB

922

7744 (8)

5130 (6)

1392 (2)

1256 (1)

5540 (6)

aldehyde dehydrogenase

PA5302

dadX

53

2770 (52)

359 (7)

468 (9)

297 (6)

1947 (37)

alanine racemase

105

3934 (37)

493 (5)

438 (4)

359 (3)

2826 (27)

PA5303
PA5304

dadA

165

5682 (34)

755 (5)

793 (5)

685 (4)

3842 (23)

D-alanine dehydrogenase

PA0265

gabD

448

6923 (15)

6247 (14)

1889 (4)

2161 (5)

4434 (10)

succinate-semialdehyde dehydrogenase

PA0266

gabT

721

9244 (13)

7800 (11)

3199 (4)

3617 (5)

6136 (9)

4-aminobutyrate aminotransferase

PA5313

gabT2

144

4226 (29)

1426 (10)

107 (1)

146 (1)

2095 (15)

pyridoxal-dependent aminotransferase

91
104 (1)
88 (1)
PA5314
2298 (25)
666 (7)
1385 (15) hypothetical protein
The PA ID numbers were taken from the PAO1 genome annotation project (www.pseudomonas.com).
b
GeneChip raw data are mean values from two independent sets of cultures. Cells were grown in minimal medium P supplemented with 20 mM of the following
supplements as indicated: Glu, glutamate; Put, putrescine; GABA, -aminobutyrate; Lys, L-lysine; Cad, cadaverine; AMV, -aminovalerate; Spd, spermidine.
Fold changes are in parenthesis.
a
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Table 2.3. Growth phenotypes of pauA mutants on polyamines, GABA, and AMV

Carbon Sources*

Strain
Cad

AMV

Put

GABA

Spd

WT

+

++

++

++

++

pauA2

+

++

++

++

-

pauA1

++

++

++

++

++

pauA4

++

++

++

++

++

pauA5

++

++

++

++

++

pauA1/4

++

++

+

++

++

pauA1/5

+

++

++

++

++

pauA4/5

++

++

++

++

++

pauA1/2/4

++

++

-

++

++

pauA1/4/5

-

++

+

++

++

pauA1-6

-

++

-

++

-

* Cells were grown on MMP media agar plates with the indicated
supplements as the sole source of carbon: Cad, cadaverine; AMV, aminovalerate; Put, putrescine; GABA, -aminobutyrate; Glc, glucose. All
supplements were added to 10mM. Ammonia was added to 5 mM as the
sole source of nitrogen. Growth was recorded in 3 days at 37C. ++,
growth after 1 day; +, growth after 2 days; -, no detectable growth after 3
days. All unmarked deletion mutants were derived from PAO1.
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Figure 2.2. Expression profile of pauA promoters in P. aeruginosa PAO1.
Specific activities of -galactosidase expressed from pGU102 for the pauA1 promoter,
pGU101 for the pauA2 promoter, pHT2040 for the pauA4 promoter, or pHT3356 for the
pauA5 promoter, were measured from the host strains wild type PAO1 (solid bars) and
pauA1-6 mutant PAO5725 (empty bars) devoid of six glutamyl-polyamine synthetase
genes. The cells were grown in glucose/ammonia (GN) minimal medium in the presence
or absence of putrescine (P) and cadaverine (C).
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Figure 2.3. Glucose/ammonia effect on expression profile of pauA promoters
Specific activities of -galactosidase expressed from pauA promoter-lacZ fusions (same
constructs as in Figure 2.2) were measured from the host strain wild type PAO1. The cells
were grown in minimal medium P in the presence of putrescine (P) or cadaverine (C).
Empty bars represent expression levels when 10 mM putrescine or cadaverine was used as
sole source of nutrient for growth. Solid bars show repression on cadaverine utilization by
10 mM glucose and 5 mM ammonia (GN) as background nutrients while PauA expression
with putrescine remained unaffected.
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Catabolite repression on cadaverine utilization. Cadaverine and putrescine are diamines
of similar chemical structure and molecular weight. However, there was a longer lag phase (1
day) for growth on cadaverine compared to putrescine. Additionally, it was noted that even
pauA1, pauA4 and pauA5 are essential for cadaverine utilization (Table 2.3), pauA5 was only
slightly induced (3 folds) and pauA1 and pauA4 were not induced by exogenous cadaverine in
the DNA microarray data where the cells were grown in glutamate minimal media (Table 2.2).
To understand the possible effect of glutamate and other nutrient sources on these expression
patterns, pauAs expressions at the exponential growth phase were monitored in wild type PAO1
using the same promoter-lacZ fusions as in the previous section. As shown in Figure 2.3, while
all pauA promoter activities with putrescine remained unaffected by background nutrients,
expression levels with cadaverine were significantly reduced when glucose and ammonia were
added into the media. Among these four pauA promoters, pauA1 and pauA5 promoters showed
higher specific activities from the -galactosidase assays with approximately 4 folds of
difference when cadaverine was used as sole source of carbon and nitrogen. On the other hand,
pauA2 and pauA4 promoters showed lower specific activities but with high fold changes (18 and
8 folds respectively) when compared to expression levels in glucose and ammonia minimal
media. Similar phenomenon of repression was observed using glutamate minimal media (data
not shown) suggesting strong catabolite repression for cadaverine utilization in this organism.

Regulation of the -glutamylation pathway. Based on studies in E. coli, -glutamylation
pathway is negatively regulated by PuuR (44). The puuR counterpart in P. aeruginosa, PA5301,
was replaced by a gentamicin resistance cassette in the mutant strain PAO5722. While there is no
significant effect on growth in either LB or glutamate (data not shown), the four pauA promoters
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(from previous sections) showed constitutive expression levels in PAO5722 (Figure 2.4). This
strongly suggests a regulatory role of PA5301 in the pathway thus I designated this gene as
polyamine utilization regulator, pauR.

Binding of PauR on pauA promoters were successfully proven in vitro. PauR was purified to
homogeneity as described in Methods and subjected to electrophoretic mobility shift experiments
using the same regulatory regions of the four pauA genes as in expression measurements. As
shown in Figure 2.5A, clear binding on pauA1-2 (divergent promoters), pauA4 and pauA5 were
detected with high affinity. However, when I tested for effect of polyamines by adding 1 mM of
putrescine or cadaverine in the reaction, no apparent effect on the binding was detectable
(Figures 2.5B and 2.5C). This intrigued me, so I performed PauR (24 KDa) glutaraldehyde
crosslinking analysis to see changes in PauR in response to polyamines. As shown in Figure
2.5D, distinct PauR homo-dimmer formation was detected after crosslinking. When putrescine or
cadaverine was added into the reaction, the monomeric and dimeric bands became diffused with
a slight increase in molecular weight on SDS PAGE. This change is specific to putrescine and
cadaverine but not to diaminopropane, a diamine with shorter methylene chain. As controls,
polyamines were added after the crosslinking reaction and no change was detectable in these
samples indicating that band diffusion was not due to the presence of polyamines during
electrophoresis. This data suggests that PauR regulates the -glutamylation pathway through
conformational changes in response to putrescine/cadaverine.
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Figure 2.4. Effects of pauR on expression profiles of the pauA promoters
Specific activities of -galactosidase expressed from pauA promoter-lacZ fusions (same
constructs as in Figure 2.2) were measured from the host strains wild type PAO1 (solid
bars) and pauR mutant PAO5722 (empty bars). The cells were grown in minimal medium
P supplemented with glucose (G) as the sole source of carbon, and putrescine (P),
cadaverine (C), or ammonia (N), as the sole source of nitrogen.
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Figure 2.5. PauR binding on pauA promoters.
A, B and C. PauR binding on pauA1-2, pauA4 and pauA5 promoters. Interactions of
purified His-PauR with radioactively labeled pauA promoter regions were demonstrated
by the electrophoretic mobility shift assays. No evident effects of polyamines on PauR
binding were detectable by adding 1mM of putrescine or cadaverine in the reaction
mixture, gel, and running buffer (B and C). D. PauR conformation change in response
to putrescine and cadaverine. PauR showed distinct dimmer formation after
glutaraldehyde crosslinkage (lane 3). Putrescine and cadaverine, but not diaminopropane,
seemed to induce conformational changes (lanes 4 to 6). As negative controls,
polyamines were added after the termination of crosslinking reaction (lanes 7 and 8). No
glutaraldehyde was added in the reactions of lanes 9 and 10.
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Common enzymes for GABA and AMV catabolism. GABA and AMV are the
corresponding downstream metabolites of putrescine and cadaverine in the -glutamylation
pathway (Figure 2.1) (12, 13, 42). Based on previous reports of our laboratory, gabDT and
gabT2 code for two transaminases and a succinic semialdehyde dehydrogenase essential for the
two-step degradation of GABA into succinate (13). Due to similarities in chemistry, overlaps in
putrescine/cadaverine catabolic pathways may extend to GABA/AMV degradation. To prove
this hypothesis, I tested the GABA catabolic genes for AMV. As expected, growth on AMV was
completely depleted in gabT/T2 double mutant PAO5704 suggesting essential roles of these
transaminases in both GABA and AMV utilization (Table 2.4). In contrast, leaky growth of
gabD mutant PAO5701 on AMV suggests alternative route for glutarate semialdehyde
degradation.

Two promoter-lacZ fusions pMH105 (covering 718 base pairs upstream from the gabDT
coding region) and pHT5313 (covering the entire intergenic region upstream the gabT2 coding
region) were transformed into wild type PAO1 to see how these candidate genes respond to
exogenous GABA and AMV. While these loci were highly induced (6 folds) by exogenous
GABA, expression patterns with exogenous AMV showed no response of the gabDT promoter,
and only two-fold induction of the gabT2 promoter was detected in tested conditions (Figures 2.6
and 2.7).
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Table 2.4. Growth phenotypes of mutants with compromised GABA/AMV utilization.
Nutrients*
Strain

Genotype

PAO1

Cad

AMV

Put

GABA

Glc

wild type

++

++

+++

+++

+++

PAO5701

gabD

+

+

+

+

+++

PAO5703

gabT

+

+

+++

+++

+++

PAO5708

gabT2

++

++

+++

+++

+++

PAO5704

gabT/T2

-

-

+++

+

+++

H103

wild type

++

++

+++

+++

+++

PAO5723

agtS

++

-

+++

++

+++

PAO5724

agtA

+

-

+++

+

+++

* Cells were grown on MMP media agar plates with the indicated
supplements as the sole source of carbon: Cad, cadaverine; AMV, aminovalerate; Put, putrescine; GABA, -aminobutyrate; Glc, glucose.
Ammonia was added as the sole source of nitrogen. Growth was recorded in
3 days at 37C. +++, growth after 1 day; ++, growth after 2 days; +, growth
after 3 days; -, no detectable growth after 3 days. The gab mutants were
derived from PAO1, and the agt mutants were derived from H103.
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Figure 2.6. Expression profile of the gabDT promoter
Specific activities of -galactosidase expressed from pMH105 for the gabD promoter
covering 740 base pairs upstream from the coding region were measured from the host
strains wild type PAO1, gabT mutant PAO5703 and gabD mutant PAO5701. Constitutive
activation was detected in gabD mutant suggesting succinate semialdehyde as the inducer
molecule of the operon. The cells were grown in glutamate (Glu) minimal medium in the
presence or absence of-aminobutyrate (GABA), -aminovalerate (AMV), or succinate
semialdehyde (SSA).
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Figure 2.7. Expression profile of gabT2 promoter.
Specific activities of -galactosidase expressed from pHT5313 for the gabT2 promoter
were measured from the wild type strain PAO1. The cells were grown in glutamate (Glu)
minimal medium in the presence or absence of-aminobutyrate (GABA), or aminovalerate (AMV).
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SSA might be the activating signal of the gabD promoter. Deamination of GABA and
AMV by GabT/T2 leads to succinate semialdehyde (SSA) and glutarate semialdehyde (GSA),
which are further degraded by GabD into succinate and glutarate, respectively (13, 83). To
investigate the regulatory aspects of this catabolic pathway, the gabDT expression levels in
response to GABA or its downstream metabolite SSA were measured using the promoter-lacZ
fusion pMH105 in the wild type PAO1 strain. As shown in Figure 2.6, although gabDT was
inducible by both compounds, induction by GABA (5.6 folds) was stronger than SSA (3.4 folds).
This data suggested that SSA might be the inducer molecule of the gabDT operon. To test this
hypothesis, the gabD promoter activities were measured in the gabD (PAO5701) and gabT
(PAO5703) mutant strains using pMH105. Curiously, gabDT expression became constitutive in
gabD but not in gabT (Figure 2.6). Since GabD is responsible for the degradation of SSA and
GSA, the high expression levels detected in the gabD mutant could be caused by internal
accumulation of either of these aldehyde compounds. However, since AMV has only marginal
effects on the gabD promoter, its downstream metabolite GSA may not play as an activating
signal in this pathway.

Mutational analysis of the gabD promoter region. A study using serial deletions on the 5‟
end of the gabD promoter indicated essential elements for full activation reside within -290 base
pairs upstream from the transcriptional starting site (29). As shown in Figure 2.8A, this region
contains putative -70 recognition sites -10 (5‟-TAGGAT-3‟) and -35 (5‟-TTGCCC-3‟) with 17
base pairs of distance between these two boxes. The +1 position was suggested based on
published data from P. putida (83). At the transcription starting site, a 18 base-pairs-long
sequence with dyad symmetry (5‟-CGTTTGAGATTTCAAACG-3‟) was found highly
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conserved among different Pseudomonas suggesting a regulatory role involved. Two gabDT
promoter-lacZ (transcriptional) fusions, pHT0265-1 and pHT0265-2, differing in this palindrome
were constructed in order to test for differences in response to GABA and AMV. As shown in
Figure 2.8B, gabDT exhibit high background expression levels when this palindrome was
removed from the promoter region. This suggests existence of a repressor protein for gabDT
induction.

Effects of PauR on the gabD promoter. Direct interaction between GabD and its own
promoter may serve as an alternative explanation of the high expression levels of pMH105 in the
gabD mutant strain PAO5701. I tested for in vitro binding of purified His-GabD to the full
length promoter region amplified from pMH105. No apparent interaction was detected using
electrophoretic mobility shift experiments (data not shown). Therefore, the possibility of a direct
regulation by GabD on its own promoter was excluded. On the other hand, the general repressor
form the -glutamylation pathway, PauR, may extend its regulation to the utilization of these
downstream metabolites. Indeed, higher levels of gabDT and gabT2 expression were detected in
the pauR mutant (Figure 2.7 and 2.8B). While the background levels of the gabD promoter in the
pauR mutant were elevated to the induced level in PAO1 by GABA, the background expression
levels of the gabT2 promoter were lower than the induced level in PAO1 by GABA.
Additionally, removal of the palindrome at the +1 site caused further induction of the gabD
promoter in the pauR mutant strain (Figure 2.8). These data suggested a more complex
regulatory system for GABA and AMV utilization other than a single repressor protein in this
organism.
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Figure 2.8. PauR regulation on the gabD promoter.
A. Schematic presentation of three PgabD::lacZ promoter fusions used in this study.
Also shown is the sequence comparison of the gabDT promoters from indicated species
of pseudomonads. Well-conserved palindromic sequence downstream the -10 and -35
motifs is marked with dashed arrow. The transcriptional starting site is in larger font. PA,
P. aeruginosa; PS, P. syringae; PF, P. fluorescens; PP, P.putida; PE, P. entomophila.
B. Effects of the palindrome on the expression profiles of the gabD promoter. Expression
of the gabD promoter-lacZ fusions pHT265-1 (with palindrome, solid bars) and pHT2652 (no palindrome, empty bars) were monitored by measurements of -galactosidase
activity in the host strains wild type PAO1 and pauR mutant PAO5722. The cells were
grown in glucose/ammonia (GN) minimal medium in the presence or absence ofaminobutyrate (GABA), or -aminovalerate (AMV).

66

Figure 2.9. PauR binding on gabDT promoter.
PauR binding on gabDT regulatory region was demonstrated using electrophoretic
mobility shift assays as described in Methods. Highest PauR concentration used was 6
nM followed by 2 fold serial dilutions. Promoter regions from pHT0265-1 and pHT02652 gabD promoter-lacZ fusions differing in the palindromic sequence at the +1 site (as
shown in Figure 2.8A) were used as probes in the left and right panels, respectively. Free
probes were in the last lane.
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Binding of PauR on the gabD promoter. To further confirm the role of pauR as a repressor,
binding of PauR to the gabDT promoter region was demonstrated by electrophoretic mobility
shift experiments (Figure 2.9). No apparent difference in binding was detectable when the
promoter lacking the highly conserved sequence as described above (Figure 2.8A) was used as
probe, which indicated that this palindromic sequence is not a PauR operator site.
Conformational change in PauR was also tested using the glutaraldehyde crosslinking
experiment as described in previous section, and no change was detectable when GABA or
AMV was added in the reaction (data not shown). These data support PauR as a repressor protein
on gabD and gabT2 promoter.

These data confirmed that like putrescine/cadaverine, significant overlaps were found for
GABA/AMV catabolism. The role of PauR was expanded to a general regulatory protein of the
pathways from putrescine/cadaverine glutamylation to GABA/AMV degradation. However,
possibilities of additional regulatory system(s) are not excluded since interacting mechanisms on
the palindromic sequence of the gabD promoter still await identification.
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Table 2.5. Expression profiling of the agt locus by DNA microarray
Signal Valueb
PA IDa

Gene
Name

Glu

Glu

Glu

Glu

Glu

Glu

Arg

Put

GABA

Lys

Cad

AMV

Descriptions

PA0600

agtS

169

78 (0)

157 (1)

101 (1)

156 (1)

57 (0)

103 (1)

two-component sensor

PA0601

agtR

266

225 (1)

326 (1)

220 (1)

262 (1)

305 (1)

262 (1)

two-component response regulator

158

174 (1)

100 (1)

90 (1)

268 (2)

300 (2)

255 (2)

PA0603

agtA

432

497 (1)

1007 (2)

8165

1904 (4)

4269 (10)

7581 (18)

putative periplasmic binding protein
ATP-binding component of ABC transporter

PA0604

agtB

341

481 (1)

514 (2)

4520

1102 (3)

1998 (6)

3127 (9)

binding protein of ABC transporter

PA0605

agtC

201

21 (0)

340 (2)

4767

693 (3)

2118 (11)

2259 (11)

permease of ABC transporter

PA0606

agtD

131

230 (2)

224 (2)

3136

448 (3)

927 (7)

1341 (10)

permease of ABC transporter

PA0602

a

Glu

The PA ID numbers were taken from the PAO1 genome annotation project (www.pseudomonas.com).
GeneChip raw data are mean values from two independent sets of cultures. Cells were grown in minimal medium P supplemented with 20 mM of the following
supplements as indicated: Glu, glutamate; Arg, L-arginine; Put, putrescine; GABA, -aminobutyrate; Lys, L-lysine; Cad, cadaverine; AMV, -aminovalerate.
Fold changes are in parenthesis.
b
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Different responses to endogenous and exogenous GABA and AMV. Based on DNA
microarray analysis shown in Table 2.5, PA0603-PA0605 were picked up among the entire
transcriptome as the only locus inducible specifically by exogenous GABA (15~24 folds) but not
by endogenous GABA produced from putrescine degradation (13). Following the logic that
genes for GABA utilization may have relaxed specificity with AMV, I tested the importance of
this transport system for both GABA and AMV utilization. As revealed from genetics studies,
growth on GABA and AMV were severely affected in PA0603 (ATPase) mutant strain PAO5724
(Table 2.4). While this transport system seemed essential for AMV uptake, growth on GABA
was reduced but not completely depleted in PAO5724. This implies alternative uptake system(s)
for GABA in this organism. Based on this information, PA0603~PA0605 were designated as
AMV/GABA transport genes agtABCD. The gene organization with predicted functions was
shown in Figure 2.10A.

Upstream of the agtABCD operon, the PA0602 gene encodes another putative periplasmic
solute-binding protein exhibiting 79% sequence similarity to AgtB. Because PA0602 is not
present in other Pseudomonas, and it was not inducible by GABA based on the DNA microarray
analysis, it was excluded from the agtABCD operon.

Expression of the agtABCD operon responds exclusively to exogenous GABA/AMV. To
verify my DNA microarray data, I used PAO1 harboring pHT0603 (agtA::lacZ) to test for
responses of the Agt transport system to exogenous GABA/AMV. As shown in Figure 2.10B, the
agtA promoter is distinctly induced by exogenous GABA (20 folds) and AMV (27 folds) when
compared to the corresponding upstream precursors putrescine (2 folds) and cadaverine (3 folds).
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Figure 2.10. The Agt transport system.
A. Schematic presentation of the gene organization of the agt locus. The agtSR twocomponent system and the agtABCD transport system genes for GABA and AMV uptake
are highly conserved among Pseudomonas. PA0602 located between these two operons is
unique to P. aeruginosa. Insertion points of lux mutants analyzed in this study were
marked with a star: lux gene was inserted with reverted orientation at the nucleotides 1091
of the agtS coding region and with transcriptional orientation at the nucleotide 288 of the
agtA coding region. B. Agt transport system responses exclusively to exogenous
GABA and AMV. Specific activities of -galactosidase expressed from pHT0603 for the
agtA promoter were measured from the host strains wild type PAO1 and gabT1/T2 double
mutant (PAO5704) defected in GABA/AMV degradation. The cells were grown in
glutamate (Glu) minimal medium in the presence or absence of putrescine (Put),
cadaverine (Cad), GABA or AMV. C and D. AgtABCD transport system is regulated
by AgtSR two component system. Specific activities of -galactosidase expressed from
pHT0603 for the agtA promoter were measured from the host strains agtS mutant
(PAO5723), agtA mutant (PAO5724), and the parental H103. Binding of AgtR on the
agtA promoter was demonstrated using electrophoretic mobility shift assays as described
in Methods. AgtR concentrations used started at 863 nM followed by 2-fold dilutions.
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Furthermore, I used the gabT1/T2 double mutant PAO5704 defective in the transaminases
essential for the first step of GABA/AMV catabolism to accumulate endogenous GABA and
AMV from putrescine and cadaverine degradation. This data showed no evidence of agtA
induction in PAO5704 by endogenous GABA/AMV, confirming exclusive response of this
transport system to exogenous GABA/AMV (Figure 2.10B).

The Agt transport system is under positive regulation of the AgtSR two-component
system. A two-component system PA0600-PA0601 located just upstream the AgtABCD transport
system was found as a candidate regulatory system for GABA/AMV uptake. As revealed from
genetics studies, growth on AMV was completely depleted in PA0600 (sensor) mutant strain
PAO5723 (Table 2.4), but growth of this mutant on GABA was leaky because of alternative
uptake system(s) for GABA (Table 2.4). Therefore, I designated PA0600~PA0601 as agtSR twocomponent system.

AgtSR regulation on the agtABCD operon was further studied by measuring the agtA
promoter activity in the agtS mutant strain PAO5723 and its parental strain H103 harboring
pHT0603. As shown in Figure 2.10C, disruption of the sensor AgtS seemed detrimental for the
expression of the downstream ABC transport system in PAO5723. On the other hand, in an
electrophoretic mobility shift assay, agtA promoter (corresponding to pHT0603) interacted with
purified His-AgtR, and the formation of protein-DNA complexes was seen (Figure 2.10D).

As shown in previous sections, growth on GABA and AMV is compromised in PAO5724
with a defected ATPase, AgtA (Table 2.4). Curiously, when measuring the expression levels of

72

pHT0603 in PAO5724, constitutive promoter activation of the agtABCD transport system was
found in the agtA mutant strain (Figure 2.10C). This unusual pattern of promoter activities
independent of the presence of exogenous GABA/AMV suggests that the on/off switch of the
AgtRS system might be coupled with the AgtABCD transport system on the membrane.

Effect of Agt transport system on GabDT expression. I further studied the role of Agt
transport system in GABA/AMV utilization by measuring changes in catabolic enzymes
expression levels in defected uptake strain. The gabDT promoter-lacZ fusion pHT0265-1 was
transformed into PAO5723 agtS mutant to test for induction by exogenous and endogenous
GABA and AMV. As shown in Figure 2.11, induction by exogenous GABA and AMV were
significantly reduced with defected transport system. In PAO5723 agtS mutant strain, induction
by GABA showed 3 folds reduction and only basal expression level was detected for AMV. This
data strengthened the contribution of the Agt transport system in GABA and AMV utilization.

Endogenous GABA and AMV were produced as secondary metabolites from putrescine and
cadaverine degradation, respectively. In the same set of experiment, induction levels by
endogenous GABA and AMV sustained in agtS mutant strain suggesting GABA/AMV should
enter the cell to trigger gabDT expression (Figure 2.11). On the other hand, since there may be
more than one regulatory systems (other than PauR) involved in GABA/AMV catabolism, AgtR
was subjected to gel electrophoretic mobility shift experiments as candidate positive regulator on
gabDT. However, no AgtR binding was detectable on gabDT promoter region (Figure 2.12).
Therefore I concluded that AgtSR senses and responds to exogenous GABA/AMV for uptake by

73

Figure 2.11. GabDT expression in Agt transport system deficient strain.
Specific activities of -galactosidase expressed from pHT0265-1 for the gabD promoter
were measured from the host strains wild type H103 and agtS mutant (PAO5723) devoid
of the sensor component of the agt two-component system. The cells were grown in
glucose/ammonia (GN) minimal medium in the presence or absence of putrescine (Put),
cadaverine (Cad), GABA or AMV.
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Figure 2.12. AgtR binding on gabD promoters was not detected
Interactions of purified His-AgtR with gabD promoter regions were tested using the
electrophoretic mobility shift assays. Two DNA probes covering the gabD regulatory
regions with and without the palindromic sequence (corresponding to pHT0265-1 and
pHT0265-2, respectively) were used in the experiments in the presence of a non-specific
DNA fragment as negative control. Nucleoprotein complex was not detected.
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the AgtABCD transport system, but may not be involved in the regulation on gabDT operon for
GABA/AMV catabolism.

In this report I performed a detailed study of putrescine and cadaverine catabolism via the glutamylation pathway in P. aeruginosa. Different combinations of PauA(s) were shown
essential for putrescine and cadaverine glutamylation revealing functional redundancy of these
enzymes and the importance of the -glutamylation pathway in this organism. PauR was
identified as a general repressor of this pathway controlling putrescine/cadaverine glutamylation
and GABA/AMV degradation. While putrescine and cadaverine seemed to be the inducer
molecules of PauA activity, GABA degradation was shown under an unusual regulatory circuit
in which an intermediate compound, SSA, served as the activating signal molecule. Additionally,
different from putrescine, cadaverine utilization was repressed by the presence of glucose and
glutamate as reflected from the expression profiles of the catabolic genes in response to
cadaverine. This also implied additional level of repression on lysine utilization since
accumulation of polyamines has been reported to inhibit lysine decarboxylase enzyme activity
(37, 101).
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CHAPTER THREE

CATABOLITE REPRESSION BY CBRA-CBRB TWO-COMPONENT SYSTEM IN
PSEUDOMONAS AERUGINOSA PAO1

This work was partially published by Laetitia Abdou, Han-Ting Chou, Dieter Haas and ChungDar Lu in “Promoter Recognition and Activation by the Global Response Regulator CbrB in
Pseudomonas aeruginosa”. J. Bacteriol. 2011 Jun; 193(11):2784-92.
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3.1 INTRODUCTION

The CbrA-CbrB two-component system was first identified to be involved in the global
metabolic regulation of carbon and nitrogen utilization in P. aeruginosa (54, 74). While the
inducer signals for the membrane bound CbrA sensor are unknown, CbrB is a -54 RNA
polymerase dependent transcriptional activator of the NtrC family of response regulators (74).
The CbrB/CrcZ/Crc pathway to control CCR through Crc was proposed by the laboratory of Dr.
Haas in 2009 (94). The translational regulator Crc binds on mRNAs of uptake and catabolic
genes with unpaired A-rich sequences, also termed CA motives (consensus AAc/uAAc/uAA), near
their ribosome binding sites (66, 67, 94). CCR by Crc has been extensively studied in P. putida
and P. aeruginosa (for review, please refer to Rojo 2010) (86). In the CbrAB/CrcZ/Crc model,
CbrAB regulates positively the expression of the 407 nucleotide-long small-RNA CrcZ which
contains five CA motives with high affinity for Crc to compete with mRNAs in binding (94).
Remarkably, using succinate, glucose and mannitol as different carbon sources, CbrA/CbrB
gradually releases catabolite repression by adjusting CrcZ expression level to antagonize Crc to
different extends for each nutrient (94).

Other than the CbrAB/CrcZ/Crc pathway, the two-component system CbrAB has other
important targets where Crc is not involved. Direct regulation of CbrAB has been reported for
the lipA (lipase) gene in P. alcaligenes (41), and the hutU (histidine utilization) operon in P.
aeruginosa and P. fluorescens (54). CbrAB system may play important role in arginine
utilization. Promoter scan (PromScan @ Queen‟s) on aotJ-argR (arginine/lysine utilization)
regulatory region found conserved -24/-12 boxes ATGGCTTGN4TTGCT that are typical of -54
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dependent promoters (consensus TGGCACGN4TTGCT/A scored with 85 out of 100). This
sequence motif is located at 273 nucleotides upstream from the start codon of the aotJ-argR
operon. Direct binding of CbrB to the aot and hutU promoters was also proven by
electrophoretic mobility shift experiments (Wei Li; personal communication). These evidences
suggest direct regulation of CbrAB on the aot operon independently from Crc.

As mentioned in General Introduction, CbrAB and NtrBC exhibit similar protein
sequences and structures and were suggested to be functionally overlap. Suppressor mutants
from a cbrAB deficient strain PAO5100 grown on arginine can be grouped into two types:
mutants with constitutive Ntr system activation (represented by Arg18 with single mutation
Asp227Ala on NtrB) and mutants with unknown mechanism to overcome the severe metabolic
imbalance (represented by Arg34) (54). Ntr activation restores the ability to use histidine in
Arg18, but still handicapped in the utilization of TCA cycle intermediates and most carbon-only
sources. In contrast, Arg34 shows almost identical growth phenotype to the wild-type strain
PAO1, except in histidine, ornithine and hydroxyl-L-proline utilization (54). Interestingly, the
ratio of Arg34 (arginine positive, histidine negative, glucose positive) to Arg18 (arginine
positive, histidine positive, glucose negative) is high (85:5). It is possible that the ability of
Arg34 to grow on a wide range of compounds is due to mutations on CrcZ to release CCR by
Crc.

In this study, direct interaction of CbrB on the crcZ promoter was shown by
electrophoretic mobility shift experiments. Two putative upstream activating sequences (UASs)
on crcZ regulatory region were proven to contribute in CbrB recognition. Participation of
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CbrAB, Crc and NtrBC systems were analyzed for arginine, lysine, putrescine and cadaverine
catabolism using genetics approach.
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Table 3.1. Strains and plasmids
Strain or plasmid

Genotype or description a

Source

E. coli strains
DH5

TOP10

F-Φ80dlac ∆M15 ∆(lacZYA-argF)U169 deoR recA1 endA1 Bethesda
hsdR17 (rK- mK-) supE44 λ- thi-1gyrA96 relA
Research
Laboratories
Invitrogen
F- mcrA (mrr-hsdRMS-mcrBC) 80lacZM15
DlacX74 recA1 araD139 (ara-leu)7697 galU galK rpsL
(Smr) endA1 nupG

P. aeruginosa strains
PAO1

Wild type

(27)

PAO5100

 cbrAB::Gmr

(59)

PAO4727

 cbrAB::Gmr;  crc

PAO5126

 cbrAB::Gmr; ntrBC::Tcr

(54)

This study

pCBRB*

Ampr pUCP18 derivative carrying the wild type
cbrB fragment of PAO1
Ampr pUCP18 derivative carrying K98Q cbrB

pME9834

crcZ-lacZ with 116-bp promoter region; Tc

r

(1)

pME9842

crcZ-lacZ with 138-bp promoter region; Tcr

(1)

pME9843

crcZ-lacZ with 161-bp promoter region and mutated motif 2
(Mut2) in the UAS; Tcr

(1)

pSU300

pBAD/HisB carrying truncated cbrB

This study

Plasmids
pCBRB

a

Gmr, gentamicin resistance; Tcr, tetracycline resistance; Ampr, ampicillin resistance.

This study
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3.2 MATERIALS AND METHODS

Bacterial strains, plasmids, media, and growth conditions. Bacterial strains and plasmids
used in this study are listed in Table 3.1. P. aeruginosa strains were grown in Luria-Bertani (LB)
and 2X tryptone-yeast extract media (2YT) supplemented with or without antibiotics at
conventional concentrations (104). Minimal medium P (27) containing the indicated carbon
sources at 20 mM and nitrogen sources at 5 mM was used for the growth of P. aeruginosa.

Plasmid construction. Full length CbrB was amplified by PCR from the genomic DNA of P.
aeruginosa PAO1 and subcloned into pUCP18 EcoRI and HindIII sites to construct pCBRB
using the following primers: CbrB_F, 5‟-GCT GAA TTC GGC ACA TAT TCT GAT CGT CGA
AGA CG-3‟and CbrB_R, 5‟- GCT AAG CTT CTG TTA CGC GGT ACG TCC GCG GTA AC-3‟.
The K98Q mutation on CbrB was introduced into pCBRB to construct pCBRB* using the
following primers: CbrB*_F, 5‟-GTG GAC TAC ATC GCC CAG CCT TTC GAC CAC G-3‟and
CbrB*_R, 5‟-CGT GGT CGA AAG GCT GGG CGA TGT AGT CCA C-3‟.

Purification of His-CbrB. His-tagged truncated „CbrB (His-CbrB) protein was expressed
from pSU300 in E. coli TOP10 (Invitrogen). The resulting recombinant „CbrB protein lacks the
13 N-terminal amino acid residues of the native CbrB protein and carries an N-terminal His6 tag.
After induction by 0.2 % (w/v) arabinose for 3 h, cells were collected by centrifugation and
ruptured by passing through a French pressure cell at 8,500 lb/in2. Cell debris was removed by
centrifugation at 25,000×g for 30 min, and the resulting cell-free crude extract was loaded onto a
HisTrap HP column (GE Healthcare) in an AKTA FPLC system, following a purification
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protocol suggested by the manufacturer. The recombinant His-CbrB protein was eluted by 175
mM imidazole. The purity of His-CbrB in the collected fractions was verified by SDS-PAGE.
Protein concentration was determined by the Bradford method with bovine serum albumin as
standard.

Electrophoretic mobility shift assays. DNA fragments covering wild-type and mutated
regulatory regions were PCR-amplified from the genomic DNA and plasmids as described in
Abdou et al (2011). DNA probes were prepared by labeling them with [γ-32P]ATP and T4
polynucleotide kinase (34). Radioactively labeled DNA probes were allowed to interact with
different concentrations of purified His-CbrB in a 20-μl reaction mixture containing 50 mM TrisHCl (pH 7.5), 50 mM KCl, 1 mM EDTA, 5 % (v/v) glycerol, 150 μg/ml acetylated bovine serum
albumin, and 40 ng cold pUC18 vector as non-specific DNA. The reaction mixtures were
incubated at room temperature for 30 min before being applied to a 4 % polyacrylamide gel (bisacrylamide ratio 1:60) in 0.5 TBE buffer pH 7.5. The gel was dried, auto-radiographed by
exposure to a phosphorimager plate, scanned using FLA-7000 version 1.1, and analyzed by
Multi Gauge version 3.0 (FUJIFILM).
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Figure 3.1. Domains of the CbrB protein.
Domain map with conserved sequences in the CbrB and NtrC proteins of P. aeruginosa
PAO1, based on the domain map of Salmonella enterica NtrC (22). CbrB is predicted to
contain an N-terminal regulatory domain, a central 54 activation domain and a Cterminal DNA-binding domain with a helix-turn-helix motif (HTH). The conserved
phosphorylation site in the regulatory domain is presumed to enable activation of CbrB
by the sensor kinase CbrA (5, 30). Grey boxes below show that the 13 N-terminal amino
acid residues of the native CbrB protein are replaced by 35 different amino acids
including a his6 tag in the truncated CbrB protein.
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3.3 RESULTS AND DISCUSSION

Direct evidence of CbrB regulation on crcZ promoter. The regulator CbrB shows
similar protein structure to the well known bacterial enhancer binding protein NtrC with 43%
identity and 62% similarity in amino acid sequences. As shown in Figure 3.1, this family of
regulatory protein exhibits an N-terminal regulatory/receiver domain with a conserved aspartate
residue (D52 of CbrB) to be the cognate sensor phosphorylated by CbrA, a central domain to
interact with -54 RNA polymerase, and a C-terminal helix-turn-helix DNA binding domain. It
had been reported inhibitory effect of the regulatory domain on the binding activity of some
members of the NtrC family and truncation of the N terminus can enhance this activity (25, 77).

Here I study the direct regulation of CbrB on CrcZ promoter as suggested in
CbrAB/CrcZ/Crc model. Full length and truncated His-tagged CbrB protein were over-expressed
and purified from E. coli and subjected to electrophoretic mobility shift experiments as described
in methods. In general, optimal conditions for in vitro binding activity of CbrB was very hard to
find and only the truncated CbrB lacking the 13 N-terminal amino acid residues was able to
show binding on crcZ promoter in tested conditions (Figure 3.2, full length CbrB was not shown).

The crcZ promoter contains conserved -24/-12 boxes typical of -54 promoters (Figure
3.2). The region -151 to -125 from the transcriptional starting site of crcZ contains palindromic
sequences (TGTTAC and GTAACA separated by 14 nucleotides) which may function as UAS
elements to be recognized by CbrB. Therefore, I PCR amplified these regions containing wild
type as well as mutated sequences of these elements using constructs provided by Dr Haas as
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template (1), and subjected to electrophoretic mobility shift experiments. As shown in Figure 3.2,
deletion of both elements of the palindromic UAS (M1,2) abolished CbrB binding, whereas
either deletion of the upstream element (M1) or mutation of the downstream element (Mut2)
resulted in diminished CbrB binding. These data indicated that a single element in the UAS was
sufficient for CbrB binding. However, both elements might be needed for strong binding and full
activation of the crcZ promoter.

CbrB interaction on lipA promoter. In P. alcaligenes, the expression of the lipA gene
coding for secreted lipase is positively controlled by RpoN and by the LipQ/LipR twocomponent system, the counterpart of CbrA/CbrB in P. aeruginosa (41). A UAS has been
proposed as a LipR (CbrB) binding site At -130 to -112 of the lipA promoter (16). Here I
investigated the molecular details of the lipA promoter and its putative UAS in P. aeruginosa. In
an electrophoretic mobility shift assay, the purified His-CbrB protein interacted with the wildtype lipA promoter region at the highest protein concentration used, but caused no band shift of a
promoter fragment lacking the UAS (Figure 3.3). The relatively low affinity of His-CbrB for the
UAS in the lipA promoter reflects a suboptimal recognition sequence, by comparison with the
UAS in the crcZ promoter.
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A.

B.

Figure 3.2. His-CbrB binds to the UAS of the crcZ promoter in vitro
A. Sequence of the crcZ promoter region and recognition sites for CbrB. In the nucleotide
sequence of the crcZ promoter region, the 45-bp UAS region is highlighted in grey. The
cbrB stop codon, the motif 1 and motif 2 of the UAS, and the -24 and -12 elements of the
54 promoter are all shown in boxes. Inverted arrows show a palindromic sequence in the
UAS region; arrows with solid lines below boldface nucleotides indicate the extent of the
CbrB consensus binding site. Dashed inverted arrows show a putative -independent
terminator of the cbrB transcript. An arrow at +1 shows the start of crcZ transcription. B.
Interactions of radioactively labeled wild-type and mutated crcZ regulatory regions.
Different concentrations of purified His-CbrB were analyzed by electrophoretic mobility
shift assays. DNA probes covering crcZ promoter from the UAS region (highlighted in A)
to +1 transcription starting site were used for probes preparation as described in Methods.
WT, wild-type probe, Mut2, mutated motif 2, ΔM1, deletion of motif 1, and ΔM1,2,
deletion of motifs 1 and 2, corresponding to pME9834. Concentrations of His-CbrB in
lanes 1 to 5 were: 760 nM, 380 nM, 76 nM, 15 nM and 0 nM, respectively.
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A.

B.

Figure 3.3. Sequence of the lipA promoter region, recognition site for CbrB and catabolite repression of the lipA promoter.

A. In the nucleotide sequence of the lipA promoter, the UAS region is highlighted in
grey. The ligT stop codon, the -24 and -12 elements of the 54 promoter, and the lipA start
codon are boxed. Inverted arrows below boldface nucleotides show the palindromic
sequence in the UAS region. An arrow at +1 shows the start of lipA transcription. B.
Interactions of the radioactively labeled wild-type lipA promoter corresponding to
pME9831 (PlipA; 0.1 nM) with different concentrations of His-CbrB were tested in vitro
by electrophoretic mobility shift experiments as described in Methods. Concentrations of
His-CbrB in lanes 1 to 5 were: 1520 nM, 760 nM, 380 nM, 190 nM and 0 nM,
respectively. The crcZ promoter region devoid of motifs 1 and 2 (ΔM1,2) served as
negative controls in lane 6 (no His-CbrB) and lane 7 (1520 nM of His-CbrB).
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CbrAB/CrcZ/Crc may play partial role in regulation of basic amino acids and
polyamines utilization. When CbrAB is deficient, no CrcZ will be expressed to antagonize Crc
repression resulting in permanent inactivation of target pathways. Histidine and arginine
utilization has been thought to be regulated by CbrAB two-component system independent from
CCR by Crc. In this study, as a continuation from previous chapters, I tested for growth of
mutant strains cbrAB (PAO5100), cbrAB/ crc (PAO4727), and cbrAB/ntrBC (PAO5126), on
positively charged biomolecules such as L-histidine, L-arginine, L-lysine, agmatine, putrescine
and cadaverine. Since CbrA-CbrB and Crc are for carbon regulation, and NtrB-NtrC for nitrogen,
no growth difference between cbrAB and cbrAB/ntrBC mutant strains was expected when
nutrients were provided as sole source of carbon and nitrogen. In contrast, comparison between
cbrAB and cbrAB/ crc mutants was quite interesting; it can differentiate catabolism that is
controlled by cbrAB alone or by the coordinated cbrAB/CrcZ/Crc system. As shown in Table 3.2,
different growth patterns were obtained for L-histidine from L-arginine and polyamines. While
histidine utilization seemed independent from Crc repression, growth on L-arginine, agmatine
and polyamines were partially restored when crc was further mutated in cbrAB genetic
background to release CCR (PAO4727). This data suggested involvement of the cbrAB/CrcZ/Crc
system in the utilization of arginine, lysine, agmatine, putrescine and cadaverine. In contrast,
growth on GABA and AMV were just slightly affected in CbrAB.
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Table 3.2. Growth phenotypes of CbrAB, Crc and NtrBC mutants

Genotype
Nutrients*

wild type

cbrAB

cbrAB
crc

cbrAB
ntrBC

Histidine

++++

-

-

-

Arginine

++++

-

++

-

Agmatine

++++

-

+++

-

Putrescine

++++

-

+++

-

GABA

++++

+++

++++

+++

Lysine

+

-

+

-

Cadaverine

++

-

+

-

AMV

+++

++

+++

+

* Cells (104) were grown on MMP media plates
supplemented with 10 mM of different energy sources.
Growth was recorded during 3 days of incubation period.
++++: prominent growth after 1 day; +++: good growth after
1 day; ++: good growth after 2 days; +: growth after 3 days; -:
no detectable growth after 3 days.
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Figure 3.4. Proposed CbrB consensus in P. aeruginosa
The CbrB binding sites in the crcZ and lipA promoters of P. aeruginosa were determined
in this work. Preliminary data on the aotJ promoter of P. aeruginosa reveal similar
conserved palindromic sequences. Their alignment suggests a consensus CbrB binding
site with variable spacer lengths of 3, 12 or 28 nucleotides.
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Possible cross-talk between NtrBC and CbrAB was not found. Combined regulation
of CbrAB with NtrBC has been reported for arginine and histidine utilization in pseudomonas
(54, 107). Based on sequence and structure similarities, possible cross-talk may occur between
the sensors and regulators of these two-component systems. Based on studies of NtrC regulatory
phosphorylation in E. coli, replacing the lysine residue 104 by glutamine (K104Q) prevents
dephosphorylation of the aspartate residue on NtrC receiver domain (79). Based on amino acid
sequence similarity, CbrB K98Q was predicted as the corresponding mutation site of NtrC
K104Q. I introduced pCBRB and pCBRB* carrying wild type CbrB and mutated CbrB K98Q,
respectively, into wild type PAO1 and cbrAB mutant PAO5100. However, no difference in
growth was found on minimal media P agar plates where nutrients tested in Table 3.2 were
provided as the sole source of carbon and nitrogen (data not shown). These results implied CbrA
is necessary for CbrB activation and there may be no cross-talk between NtrB sensor and CbrB
regulator.

Comparison of CbrB recognition sites in P. aeruginosa. Direct binding of CbrAB were
shown for the crcZ and lipA genes in this study. Based on stronger binding of CbrB and the
palindromic symmetry of these elements on the crcZ promoter, CbrB consensus was proposed
based on the UAS of crcZ promoter (Figure 3.4). This allowed me to predict putative UASs on
aotJ promoter. Putative CbrB recognition sites were found at 455 and 419 nucleotides upstream
from the start codon of the aotJ promoter (gcGTTtCg N28cGTAACAa). These two elements
found on the aotJ promoter are almost identical to those in the lipA promoter but with a longer
spacer sequence (Figure 3.4). More studies are required to verify CbrB regulation on
arginine/lysine utilization through these elements.
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The crc and crcZ promoters were intact in Arg34. As mentioned in Introduction,
suppressor mutants obtained from cbrAB mutant on arginine plates can be classified into two
types based on their ability to growth on histidine and glucose. The Arg34 strain represents the
phenotype of the majority of these suppressor mutants with positive growth on sugars and TCA
intermediates as carbon sources but cannot grow on histidine (54). Since the CbrAB/CrcZ/Crc
pathway affects a wide range of metabolic pathways, mutations in genes of this pathway may
release from the permanent repression of Crc. To verify this hypothesis, I PCR amplified the
regions of the crc gene and the crcZ gene (covering coding and upstream intergenic regions) for
DNA sequencing analysis. However, the results revealed no difference in these regions between
Arg34 and the wild type PAO1 strains (data not shown).
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GENERAL DISCUSSION

Using DNA microarray to understand microbial metabolic pathways. DNA
microarray experiments were conducted to see genome wide response to exogenous L-lysine, Larginine and polyamines in P. aeruginosa. For L-lysine utilization, this approach did not give
direct indications since important genes for L-lysine utilization identified so far in this study
were under L-arginine/ArgR control (Table 1.2). This also led to misjudge ldcA (PA1818) as a
candidate of L-arginine decarboxylase gene during the initial studies of our laboratory (29).
Fortunately, growth phenotype studies were able to explain the microarray data with the peculiar
connection between L-lysine and L-arginine catabolism as reported in this study (Chapter I).

With a relatively large genome of 5,570 open reading frames, traditional genetic
approaches such as random mutagenesis may be difficult for the identification of candidate genes,
especially when there were several homologous genes with relaxed specificity such as the case of
seven -glutamyl-polyamine synthetases for polyamine catabolism (Chapter II, Table 2.2).
Different from putrescine, cadaverine is under catabolite repression from other energy sources
such as glutamate. Since all cells were grown in glutamate minimal media for this set of DNA
microarray data, response to cadaverine was severely inhibited. Therefore, candidate genes for
the -glutamylation pathway (pauA, pauB, pauC and pauD) were selected based on putrescine
DNA microarray. Roles of these genes in cadaverine utilization were also confirmed by
promoter-lacZ fusions and genetics studies. Additionally, it was unusual that almost all genes
inducible by putrescine or agmatine were also inducible by GABA (Table 2.2). It is intriguing
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that genes responsible for the -glutamylation pathway were inducible by the downstream
metabolite GABA where feedback inhibition is commonly found.

Besides the proposed oxidative deamination by PauB from E. coli, an alternative
transamination reaction was suggested for the second step of the -glutamylation pathway
regardless of the oxygen level (Figure 2.1). The transaminase SpuC was proposed for this
alternative route with L-alanine production from pyruvate. Interestingly, an induced dadAX
operon was found to ensure the recycling of pyruvate for the transamination reaction (Table 2.2)
(13, 28). This data implies contribution of this alternative route in polyamine utilization.

Clinical decarboxylase assay could be modified for P. aeruginosa detection.
Pseudomonas

aeruginosa

causes

constant

life-threatening

infections

to

hospitalized

immunocompromised patients due to its versatile metabolic capacity and quick antibiotic
resistance development (17, 87). One of the most common clinical procedures for identification
of Enterobacteriaceae and other gram-negative enteric bacilli is the biochemical differentiation
using decarboxylase media (61). This colorimetric test is based on pH changes first by sugar
fermentation followed by activation of arginine dihydrolase and lysine and ornithine
decarboxylases as part of acid stress response. Because of its low cost and simplicity, this
approach is widely used before more expensive and time-consuming experiments such as PCR or
DNA microarray for identification. While I demonstrated that L-lysine decarboxylation is the
main route of L-lysine catabolism in P. aeruginosa, this test is negative for this organism. It is
generally believed that P. aeruginosa is not adequate due to its inability to ferment certain sugars
under anaerobic conditions. This may be true for the acid stress response through arginine and
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ornithine decarboxylation, however, the lysine decarboxylase identified in this study exhibits
optimal conditions at physiological pH. Since the bottle neck of lysine decarboxylation is the
inducer arginine, it may be useful adding some arginine and adequate pH sensors in the media to
identify P. aeruginosa. This early identification may be of primordial importance to avoid
delayed treatment for immunocompromised patients in intensive care units.

Methods for lysine decarboxylase assay. In the first part of this study, I performed the
enzyme characterization of lysine decarboxylase LdcA using radiolabeled [14C]-L-lysine (98).
This radiometric method may be one of the most traditional approaches for biochemical enzyme
characterization which is generally avoided because of the usage of isotope. Other laborious
methods include manometric and multi-step spectrophotometric approaches (4, 78). The most
recent advance for this enzymatic reaction uses macrocycle-fluorescent dye complexes to allow
continuous monitoring of the product production (30). Actually, our laboratory selected this new
method as my first test for LdcA characterization using the macrocyclic cation receptor
cucurbit[7]uril (CB7) and Dapoxyl complex. The idea is based on the differential affinity
between lysine and cadaverine (product of decarboxylase) to CB7. Ideally, it should be able to
monitor the change in fluorescence when Dapoxyl is titrated out throughout cadaverine
production. Unfortunately, even this method is successful using lysine decarboxylase from E.
coli at pH 6.0, I found it impossible for my enzyme because the fluorescence intensity is tenfolds weaker at the optimal pH of my enzyme (data not shown). Therefore I concluded that this
approach is not adequate for a complete enzyme characterization.
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The second method I tested was the spectrophotometric approach using 2,4,6trinitrobenzenesulfonic acid (TNBS). This multi-step assay takes the advantage of the water
insolubility of the complex formed by cadaverine and TNBS which can be extracted by toluene
(78). This method has been widely used for three decades and most reports on lysine
decarboxylase consider it as a standard procedure for enzymatic reaction. Curiously, I found a
dramatic drop in LdcA enzyme activity once it reaches the maximum velocity around 5 mM
lysine concentration suggesting strong substrate inhibition kinetics (Appendix A). Similar pattern
was published in the original paper where this method was developed by Phan at al in 1981.
However, when I tried to analyze the enzyme kinetics with this set of data using GraghPad Prism
5 software, the inhibitory effect is so strong that the values cannot fit into the substrate inhibition
equation using non-linear regression curve fit (Figure A.2). This intrigued me, so I used the
radiometric approach to double confirm my doubt. Surprisingly, the kinetics obtained from this
old-fashioned method was totally different from previous approaches exhibiting cooperative
substrate activation pattern (Figure 1.1). Therefore, I decided to perform the complete enzyme
characterization using this last method because of the simplicity and stability in chemistry which
may cause minimal secondary effects in the reaction.

Instability of the pauA mutants. The presence of seven glutamyl-polyamine synthetases
in P. aeruginosa cause technical difficulties to conduct genetic analysis. The serial cloning
conducted by our laboratory for different combination of pauA(s) knockouts with markerless
gene replacement using the Flp-FRT recombination system was an extensive work (32, 105).
This was not only because of the large number of genes and possible combinations; one of the
problems that I encountered was the instability between FRT cassettes with proximal locations.
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For the case of mutants containing pauA1 and pauA2 double mutations, the chromosome
fragment between them (which includes spuA gene) may be unexpectedly inverted by the FRT
cassettes. To avoid this, I had to leave the gentamicin resistant cassette in either pauA1 or pauA2.
Additionally, the physiology of the mutant strain M7 devoid of all PauA1-7 is significantly
different from the wild type PAO1. This may be due to its inability to use polyamines. And I
encounter difficulties to perform chemical transformation experiments with this strain.
Therefore, the M6 mutant PAO5725 with gentamicin resistance cassette on pauA2 was used in
Chapter II for experiments involving transformation since this mutant strain has all pauA(s) for
diamine utilization mutated/deleted and exhibits same growth phenotype than M7 on putrescine
and cadaverine.

Difficulties with handling purified His-CbrB protein. In the last part of this thesis,
recognition sites for the CbrB response regulator have been identified in the upstream region of
the crcZ and lipA promoters. This interaction allows CbrB to drive the expression of the small
RNA CrcZ which antagonizes the CCR repression by Crc in P. aeruginosa. The purification
procedure and in vitro binding experiments were not easy for CbrB due to the high instability of
purified protein and sub-optimal conditions for protein-DNA interaction. Different expression
and purification schemes were tested to yield soluble active CbrB protein of high purity. HisCbrB can only be expressed at 37C and detergent or glycerol was required to avoid immediate
precipitation. Furthermore, without the N-terminal truncation, in vitro interaction between DNA
with native CbrB or full length His-CbrB was not detectable in the electrophoretic mobility shift
assay. I also tested for different binding and gel electrophoretic conditions by changing the
buffer, pH, temperature, salt, DTT, etc. However, the affinity calculated from the best set of data
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still showed poor interaction of CbrB on proposed binding sequences. I also encountered
difficulties in performing CbrB footprinting with crcZ and lipA promoters. The DNase I
digestion worked perfectly. However, there was no footprinting even with the wild type crcZ
probe. It turned out that the recombinant His-CbrB was very sensitive to Mg2+ ion which was
necessary for the DNase I activity.

Different functions of CbrAB/CrcZ/Crc regulation were proposed. Recent reports
have extended the functions of the CbrAB/CrcZ/Crc signal transduction pathway beyond the
control of catabolic pathways. A proteomic analysis has shown Crc repression on some porins
biosynthesis affecting the susceptibility to certain antibiotics (56). Decreased biofilm formation,
motility and cytotoxicity were also noted in cbrB and crcZ mutants (106). However, opposite
effects were observed by another group on biofilm formation when rich media was used (71). It
has been reported in several bacterial species that CCR systems can influence the expression of
genes related to virulence (24). It is possible that with severe defects on the regulation of
metabolism as in the cbrAB mutants, virulence traits might be directed to facilitate access to new
sources of nutrients.

Throughout these series of studies on basic amino acids and polyamine catabolism, I am
amazed by the large metabolic capacity and versatility of Pseudomonas aeruginosa. How this
bacterium develop a connection to the complex arginine network for lysine utilization, the
number of redundant enzymes in several steps of the -glutamylation pathway, and the
sophisticated metabolic regulation by CbrA-CbrB and Crc, deserve our respects for its incredible
metabolic flexibility and survival ability in different environments.
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APPENDIX A

DIFFERENT LDCA ENZYME KINETICS IN SPECTROPHOTOMETRIC PPROACH
As mentioned in General Discussion, different methods were tested for lysine
decarboxylase enzyme kinetics studies.

In this section, a widely used spectrophotometric

approach was tested for initial enzyme characterization (78). However, the kinetics obtained
using this method was significantly different from the data using radiolabeled lysine as in
Chapter One.

LdcA protein purification. The construct pHT1818 from Chapter One was used for full
length LdcA expression and purification form E. coli TOP10 as described before (52, 103). As
shown in Figure A1, lowering induction temperature seemed to help dramatically on the correct
folding and hence solubility of the enzyme.

Figure A.1. LdcA solubility depends on expression temperature.
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LdcA enzyme assay using spectrophotometric approach. Purified LdcA from above
section was used to test L-lysine decarboxylation in vitro. The reaction mixture contains 0 mM to
50 mM L-lysine as the substrate and 125 M pyridoxal-5‟-phosphate as the cofactor. Enzyme
activity was detected using a spectrophotometric method (78). Cadaverine and lysine can form
colorimetric adducts with 1.02 X 10-2 M 2,4,6-trinitro-benzenesulfonic acid (TNBS). Base on the
differential solubility of the reaction products in toluene, TNP-lysine and TNP-cadaverine, lysine
decarboxylation rate was quantified by measuring the concentration of TNP-cadaverine extract
from the organic phase by spectrophotometry. A standard curve was determined using
cadaverine. Readings were obtained from toluene extracts using OD at 340nm. An average
extinction coefficient for TNP-cadaverine was found to be 1.04 x 104 M-1cm-1. Enzyme kinetics
was analyzed using GraphPad Prism 5.0 and failed to fit into Substrate Inhibition Equation using
Non-linear Regression Curve Fit.
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Figure A.2. LdcA kinetics does not fit to non-linear regression curve with substrate
inhibition equation. LdcA was purified to homogeneity to perform enzyme characterization
using a colorimetric method in Tris buffer pH 8.5 as described above. Enzyme kinetics was
analyzed using GraphPad Prism 5.0.
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APPENDIX B

TRANSCRIPTOME ANALYSIS OF AGMATINE AND PUTRESCINE CATABOLISM
IN PSEUDOMONAS AERUGINOSA PAO1

This work was published by Han-Ting Chou, Dong-Hyeon Kwon, Mohamed Hegazy and
Chung-Dar Lu in “Transcriptome Analysis of Agmatine and Putrescine Catabolism in
Pseudomonas aeruginosa PAO1”. J. Bacteriol. 2008 Mar; 190(6):1966-75.
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APPENDIX C

LIST OF PUBLICATIONS ON SCIENTIFIC JOURNALS

1) Cadaverine and Putrescine Catabolism through -Glutamylation in Pseudomonas aeruginosa PAO1. Chou HT, Wu J, and Lu CD. Article in preparation

2) Promoter Recognition and Activation by the Global Response Regulator CbrB in Pseudomonas aeruginosa. Abdou L, Chou HT, Haas D, and Lu CD. J Bacteriol. 2011 Apr
doi:10.1128/ JB.00164-11

3) L-lysine Catabolism is Controlled by Arginine/ArgR in Pseudomonas aeruginosa PAO1.
Chou HT, Hegazy M, Lu CD. J Bacteriol. 2010 Nov;192(22):5874-80.

4) Synthesis and evaluation of new antagonists of bacterial quorum sensing in Vibrio harveyi.
Peng H, Cheng Y, Ni N, Li M, Choudhary G, Chou HT, Lu CD, Tai PC, Wang B.
ChemMedChem. 2009 Sep;4(9):1457-68.

5) Inhibition of quorum sensing in Vibrio harveyi by boronic acids. Ni N, Choudhary G, Peng
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6) Structure-based discovery and experimental verification of novel AI-2 quorum sensing inhibitors against Vibrio harveyi. Li M, Ni N, Chou HT, Lu CD, Tai PC, Wang B.
ChemMedChem. 2008 Aug;3(8):1242-9.

7) Identification of boronic acids as antagonists of bacterial quorum sensing in Vibrio harveyi.
Ni N, Chou HT, Wang J, Li M, Lu CD, Tai PC, Wang B. Biochem Biophys Res Commun.
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